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Abstract 
Current methods to study enhancers in vivo involved integrating DNA sequences into 
the genome in a random position, in zebrafish the transposase Tol2 is utilised. 
However, this random genome integration can result in position effects which cause 
variations in reporter gene expression patterns preventing conclusions from being 
drawn about the enhancer being tested. To address the issue of variable position 
effects when using random integration techniques to study enhancers, this project 
aimed to establish a PhiC31 integrase system of targeted transgenesis in zebrafish. 
Firstly, we designed and tested a multicomponent system including a recipient vector, 
donor vector and PhiC31integrase mRNA. These components were co-injected into one 
cell stage embryos to test the integration function of PhiC31 integrase in zebrafish. The 
integration was detected by designing the recipient and donor vectors such that a switch 
from GFP to mCherry lens expression marks embryos with legitimate recombination. 
Over 97% of fluorescent embryos showed mCherry expression in the lens after co-
injection of the three components indicating that integration of the two vectors by PhiC31 
integrase is highly efficient. Legitimate recombination was shown to have occurred 
using PCR and sequencing techniques from total RNA extracted from embryos. A 
recipient transgenic line was made into which the donor vector and PhiC31 integrase 
RNA were co-injected. This resulted in around 70% of fluorescent embryos showing 
mCherry expression in the lens which suggests targeted genome integration is also 
efficient in zebrafish embryos. To establish whether variability of positional effects could 
be reduced using this system, an enhancer-promoter-reporter construct was modified to 
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include donor vector sequences and injected into recipient line transgenic zebrafish 
embryos. Expression patterns observed in stable lines made with either Tol2 
transposase or PhiC31 integrase suggest that variability in position effects is reduced 
when using the PhiC31 integrase system. Together, these results provide evidence that 
the PhiC31 integrase system I have tested is suitable for a number of uses in zebrafish, 
including enhancer screening. 
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1 INTRODUCTION 
1.1 Gene Regulation 
Controlled differential gene expression is vital for cell survival, cell differentiation and 
cellular processes including apoptosis, proliferation and specific cellular function 
(Beuling et al. 2012). The regulation of gene expression predominantly occurs at the 
stage of transcription initiation and in eukaryotes RNA Polymerase II is responsible for 
transcribing protein-coding genes (Sims et al. 2004). The initiation of transcription can 
be regulated by regulatory DNA that effects gene expression but is not protein-coding 
sequence (cis-regulatory elements) (Bonn & Furlong 2008). These cis-regulatory 
elements can be adjacent to the core promoter, referred to as proximal promoters 
(Tanimoto et al. 2008); or they can be up to 1 mega base (Mb) away from the promoter, 
known as enhancers (Amano et al. 2009). The combination of these regulatory 
sequences leads to strict spatial and temporal control of tissue- and stage-specific 
genes (Sharpe et al. 1998). Loss of function of these regulatory sequences can cause a 
number of genetic diseases and so it has become clear that the study of regulatory DNA 
is highly important to understand these genetic disorders. For example, the lack of strict 
spatial and temporal control of sonic hedgehog (SHH) expression in humans can lead to 
the growth of extra digits, preaxial polydactily, when SHH is ectopically expressed in the 
anterior limb during development (Maas et al. 2011). 
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1.1.1 Core Promoter 
The core promoter is the minimum DNA sequence required for transcription to be 
initiated and usually spans a region 50 base pairs (bp) up- and down-stream of the 
transcription start site (Butler & Kadonaga 2002). Initiation of transcription is dependent 
upon recruitment of the pre-initiation complex (PIC) to the core promoter (Becker et al. 
2002). The PIC is comprised of RNA polymerase II and associated factors (including 
TFIIA, TFIIB, TFIID, TFIIE, TFIIF, and TFIIH). Different proteins in the pre-initiation 
complex bind to different motifs within the core promoter (Thomas & Chiang 2008). A 
promoter motif is a sequence of DNA that specific transcription factors bind to (Schmid 
2008). There are two models of recruitment of the PIC to the core promoter; the first is a 
sequential model as the components of the PIC are recruited to the core promoter 
separately. The other model suggests recruitment of the PIC as a pre-formed 
holoenzyme (Ossipow et al. 1995). 
Core promoter motifs 
The main core promoter motifs are listed below (Thomas & Chiang 2008). 
 TATA box (TATA) – Usually approximately 30 bp upstream of the transcription start 
site (TSS) and is bound by TBP, a subunit of TFIID. 
 Initiator (Inr) – encompasses the transcription start site and is bound by two TBP-
associated factors (TAF), TAF1 and TAF2 which are part of TFIID. 
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 Downstream core promoter element (DPE) – bound by TFIID (thought to be subunits 
TAF6 and TAF9) and is important for basal transcription. This functions with the Inr 
and the distance between these motifs is strictly regulated. 
There have been several studies showing that core promoter motifs and their positions 
in the core promoter can influence long-range cis-regulation of transcription; these will 
be discussed below. 
1.1.2 Proximal promoters 
A proximal promoter is a DNA sequence directly upstream, up to a few hundred 
basepairs, of the core promoter (Figure 1-1A; Maston et al. 2006). It often contains 
regulatory DNA which activators and repressors can bind to and influence spatial and 
temporal control of gene expression. 
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Figure 1-1 Schematic showing cis-regulatory elements influencing transcription 
(A) shows the positions of the cis-regulatory elements in relation to the core promoter. (B-D) show how 
each of the cis-regulatory elements exerts their control over gene expression. Figure adapted from 
(Maston et al. 2006). 
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1.1.3 Distal-acting cis-regulatory regions 
Cis-regulatory elements are sequences of DNA that can influence gene expression by 
either activation or repression of transcription and are located on the same chromosome 
as the core promoter. These cis-regulatory regions can act over large distances and are 
said to be distal-acting. The binding of the pre-initiation complex components to the core 
promoter motifs often requires activator proteins and mediators and it is through these 
proteins that long-range cis-regulatory elements can influence gene expression (Figure 
1-1). 
1.1.3.1 Enhancers 
Enhancers are cis-regulatory elements which usually act over large distances to activate 
transcription of specific genes (Figure 1-1B). The activator protein(s) bind to the 
enhancer through their DNA binding domain (DBD) and in turn interact with either the 
mediator complex or directly with general transcription factors to aid the recruitment of 
the pre-initiation complex (Figure 1-2) (Alberts et al. 2008). 
Activator proteins bound to the enhancer element are thought to interact with 
transcription factors bound to the core promoter and hence the enhancer and promoter 
are brought into close proximity (Figure 1-1A). Enhancers often contain a number of 
transcription factor binding sites that are bound by activators (Thomas & Chiang 2008). 
The balance of relevant transcription factors in the cell is dependent on signalling 
cascades influenced by many factors including the cell‟s environment, and the process 
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of differentiation (Zhou & Snider 2006). These transcription factors converge on the 
enhancer (called an enhanceosome) and the enhancer activates transcription from the 
target gene promoter (Pan & Nussinov 2011). The interferon-β (IFN-β) enhanceosome 
has been studied extensively and serves as a model for the activation of transcription by 
enhancers (Panne 2008). This IFN-β enhancer is located between two nucleosomes, 
one of which blocks the TATA box of the IFN-β promoter. A number of transcription 
factors including ATF-2/c-Jun dimer, IRF-3, IRF-7 and NFκB bind sequentially to the 
enhancer sequence. This enhancesome has been shown to recruit CBP/p300 
(chromatin remodeling enzymes) which re-models the chromatin revealing the TATA box 
of the IFN-β promoter and hence activating transcription (Merika et al. 1998). 
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Figure 1-2 Schematic of cis-regulatory element function in regulation of gene transcription 
The activator protein binds to the enhancer via its DNA binding domain (DBD) and can interact with TBP-
associated factors (TAFs) or mediator proteins via the activation domain (AD) which can aid the 
recruitment of the general transcription factors (GTFs) to various elements of the core promoter including 
the TATA box (TATA), initiator (Inr) and the downstream promoter element (DPE). Adapted from (Thomas 
& Chiang 2008).  
1.1.3.1.1 Identification of enhancers 
Historically cis-regulatory elements have been difficult to identify as they can be located 
at large distances from their target genes in intergenic or intronic regions. However, 
recent developments in whole genome sequencing of many organisms have made this 
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task much easier. Some of the methods employed for the identification of cis-regulatory 
elements are discussed below. 
Computational methods 
Comparative genomics has aided the identification of cis-regulatory DNA (Duret & 
Bucher 1997; Allende et al. 2006). Functional DNA including protein-coding and cis-
regulatory elements are known to be conserved throughout evolution which allows them 
to be identified by comparing the DNA sequences from the genomes of different 
species. Comparative genomics  involves comparing genomes of either many different 
similar species or of two (or more) evolutionally distant species, for example human and 
fish (Hardison et al. 1997; Goode et al. 2003; Sandelin et al. 2004). Whole genomes can 
be aligned using these methods and the putative enhancers are then functionally tested 
in vivo.  
As enhancers are known to contain clusters of transcription factor (TF) binding sites, 
these sites can be used to predict the location of cis-regulatory DNA (Berman et al. 
2002). This method has limited success on its own as not all TF binding site clusters are 
enhancers (creates false positives) but it can be useful when used in conjunction with 
other methods of identifying enhancers (Yáñez-Cuna et al. 2013). 
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In vivo methods 
A recent publication by Visel and colleagues used a ChIP-seq method where chromatin 
was immunoprecipitated with the p300 protein, which is known to be associated with 
enhancers (Visel et al. 2009). The chromatin fragments were then sequenced and 
aligned to the original genome to locate the cis-regulatory elements. This method was 
also effective in predicting when and where the putative enhancers were active 
depending on what tissue and stage were analysed. This has become a widely used tool 
to identify enhancers, however, p300 only binds to a proportion of enhancers so not all 
enhancers can be identified in this manner (Jin et al. 2011). 
Recent technological advances have resulted in a number of chromatin signatures 
associated with enhancers being identified. Histone H3 lysine 4 monomethylation 
(H3K4me1) and histone H3 lysine 27 acetylation (H3K27ac) are marks of active 
enhancers while histone H3 lysine 27 trimethylation (H3K27me3) is a marker for „poised‟ 
enhancers (Rada-Iglesias et al. 2011). Genome-wide ChIP-seq experiments pulling 
down enhancer-associated factors like p300 or modified histone marks such as 
H3K27ac can now be used as a tool to aid the identification of enhancers in fully 
sequenced genomes (Spicuglia & Vanhille 2012). ChIP-seq can also be carried out on 
specific tissues or cell types of interest to identify active enhancers in that tissue or cell 
type (Lo et al. 2011).  
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Cis-regulatory elements often fall in nucleosome free regions to allow access for 
transcription factors to bind the DNA; this leads to DNase hypersensitivity. These DNase 
hypersensitive regions (regulatory DNA) can be located using a DNase-chip method 
described in (Crawford et al. 2006). These nucleosome-free regions can also be 
identified using a method called Formaldehyde-assisted isolation of regulatory elements 
(FAIRE). This method involves cross-linking the DNA in vivo using formaldehyde and 
then shearing the DNA; the isolated DNA is fluorescently labelled and hybridised to a 
microarray (Giresi et al. 2007). 
Using a combination of both multi-species sequence comparisons and in vivo 
techniques allows enhancers to be more readily identified and studied. 
1.1.3.1.2  Verification of putative enhancers in vivo 
There have been several methods used to study enhancers in vivo. A targeted approach 
involves cloning a CNE sequence upstream of an enhancer-susceptible promoter and a 
reporter gene. This has been introduced into zebrafish eggs in a vector and the embryos 
were analysed for transient reporter expression (Shin et al. 2005). Another approach 
utilised the Tol2 transposon system to integrate the CNE-reporter constructs into the 
zebrafish genome (Fisher et al. 2006). Many functionally tested enhancers are now 
recorded in databases, for example VISTA enhancer browser contains information about 
functionally tested human enhancers (Visel et al. 2007) and the conserved non-coding 
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orthologous regions (CONDOR) database contains information about conserved non-
coding elements tested in vivo in zebrafish. 
Non-targeted enhancer trap methods have also been used to identify and study 
enhancer function which gives the advantage of genomic context (Ellingsen et al. 2005). 
A novel approach was described in 2008 using enhancer-trap methods within bacterial 
artificial chromosomes (BACs) (Shakes et al. 2008). A basal promoter-reporter gene 
construct was inserted randomly into several places along the genomic DNA in the BAC 
using a transposon system. The various modified BACs were then introduced into 
zebrafish embryos and the reporter expression pattern used to map cis-regulatory 
elements in the genomic DNA of the BAC. In this study they also found that tissue-
specificity directed by an enhancer can be context dependent. An enhancer of amyloid 
precursor protein (APP) found within intron 1 directed expression in the neurons when 
functioning with all other cis-regulatory elements, however when acting with the basal 
promoter, expression was restricted to the notochord (Shakes et al. 2008).  
One example of a gene whose cis-regulatory elements have been studied at length is 
the sonic hedgehog (shh) gene. Shh is involved in many signalling pathways controlling 
differentiation during development and so it‟s spatiotemporal expression must be tightly 
regulated. A variety of the methods described above for identifying and testing putative 
enhancers were used in the discovery of the enhancers influencing Shh expression. 
Firstly, three intronic enhancers (ar-A, ar-B and ar-C) were identified in zebrafish that 
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direct Shh expression in the notochord and floor plate (Müller et al. 1999). These 
enhancers were identified by cloning fragments of DNA from around the shh locus and 
co-injecting them with a minimal promoter-reporter construct into early zebrafish 
embryos which were analysed for reporter expression during development (Muller et al. 
1999). DNA fragments that drove expression of the reporter were further probed by 
carrying out deletions to identify the functional enhancer. Another shh enhancer (ZRS) 
was identified 1 megabase upstream of the shh TSS that mediates expression in the 
developing limb bud of the mouse (Lettice et al. 2003). This enhancer was identified 
when a preaxial polydactyly disease model mouse was investigated to find the mutation 
causing the genetic defect. In this investigation, an 8.5 kb DNA fragment was co-injected 
with a minimal promoter-reporter construct and was found to contain regulatory 
sequences. Comparative genomics was then employed to identify a conserved non-
coding region within the 8.5 kb DNA fragment which was mapped to an intron of a 
nearby gene, limb region 1 (LMBR1). Three more enhancers were identified that 
directed Shh expression in the ventral forebrain in the mouse (Jeong et al. 2006). These 
were identified using an enhancer trap construct to screen a 1 MB region around shh 
using a BAC. Another three shh enhancers were identified recently that control 
expression in the epithelial lining of the oral cavity, lung and gut (Sagai et al. 2009); they 
were identified by comparing the genomes of several mammals and teleost fish. They 
were then functionally tested and found to recapitulate endogenous Shh expression 
pattern in the epithelial lining. 
13 
 
1.1.3.1.3  Core promoters impose specificity on enhancer interaction 
In DrosoPhila, expression of the decapentaplegic gene (dpp) is controlled by an 
enhancer that is closer to two other genes, oaf and slh. Due to these genes showing 
different expression patterns, it was hypothesised that the enhancer specifically directed 
expression from the dpp promoter and not the promoters of oaf and slh (Merli et al. 
1996). To test this theory, Merli et al replaced the oaf promoter with a dpp-compatible 
promoter and oaf was shown to display the same expression pattern as endogenous 
dpp. This shows that at least a proportion of promoters must contain a sequence or 
sequences that can affect their interaction with long-range enhancers. In this sort of 
scenario we refer to dpp as the target gene and oaf and slh are bystander genes. 
Specific motifs and how they are involved in specificity of interaction with enhancers are 
discussed below. 
TATA-containing versus TATA-less promoters 
Ohtsuki and colleagues showed that some enhancers in DrosoPhila preferentially 
interact with TATA-containing promoters (AE1 and IAB5) and some interact with TATA-
containing and TATA-less promoters equally (NEE) (Ohtsuki et al. 1998). P transposon 
constructs were made containing an enhancer and two reporter genes under the control 
of two different core promoters and gene expression was analysed in transgenic 
DrosoPhila embryos by in situ hybridization using RNA probes. The constructs 
contained different combinations of core promoters; two TATA-containing promoters, 
two DPE/Inr-containing promoters or one promoter from each class. This study 
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demonstrated that some enhancers show selectivity of promoters depending on core 
promoter elements in vivo (Figure 1-3). This method did not eliminate position effects 
and so the results observed could be as a result of another cis-regulatory element in the 
area where the transgenes were integrated into the genome. 
 
Figure 1-3 Schematic showing an enhancer preferentially binding to one gene over another 
Figure adapted from (Ohtsuki et al. 1998) 
TATA versus DPE-containing promoters  
Butler and Kadonaga used an enhancer trap method to compare two promoters in the 
same genomic position (Butler & Kadonaga 2001). The enhancer trap construct was a 
transposon vector (see page 24) containing a pair of loxP sites flanking a TATA-GFP 
reporter and a pair of flippase recognition target (FRT) sites flanking a DPE-GFP 
reporter. The promoters were identical apart from the presence of either a TATA box or 
a DPE element and expression was shown to be dependent on these elements. The 
transposon was introduced into the DrosoPhila genome and stable enhancer trap lines 
were created. The Cre and FLP recombinases were then used to make pairs of sister 
DrosoPhila lines that contained either TATA-GFP or DPE-GFP in exactly the same 
position. From 18 pairs of DrosoPhila lines analysed they identified three DPE specific 
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enhancers, one TATA specific enhancer and 14 enhancers that did not show specificity 
for either TATA- or DPE-containing promoters. This method eliminated differential 
position effects on the transgenes between the pairs of lines and so the results do 
suggest that the TATA box and DPE element show specificity for certain enhancers. 
Position and distance between promoter motifs 
By sequence comparison and bioinformatics of promoters (between +500 and -100 
relative to TSS), Vardhanabhuti et al identified the importance of the position of certain 
motifs and the distance between motifs in the regulation of gene expression 
(Vardhanabhuti et al. 2007). They also suggest that the combination of these motifs 
correlates with promoters of genes showing tissue-specific expression. 
The core promoter sequence as a whole is important for transcription regulation 
Wolner and Gralla aligned the MLP (high basal transcription) and E4 (strong activation-
driven transcription) promoters according to the TATA box which was the only region 
showing conservation in 122 TATA-containing promoters that were compared (Wolner & 
Gralla 2000). The promoters were then divided into blocks which were then substituted 
between the promoters. For example the TATA block of wild type MLP was replaced by 
the TATA block of E4. By comparing the differences in general and activated in vitro 
transcription levels, they made the following conclusions: TATA and Inr elements affect 
general transcription levels but not the ratio of basal to activated transcription levels; 
however, the two blocks flanking the TATA block affect both general transcription and 
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the degree of activation. This study confirmed that not only the core promoter elements 
influence transcription regulation; the rest of the promoter sequence can also have an 
effect.  
Core promoter elements and TAFs in regulation of gene expression  
Following on from Wolner and Gralla‟s work looking at GC-rich regions flanking the 
TATA box, these regions were defined as the B recognition element (BRE) core 
promoter element (upstream GC-rich region) and the downstream GC-rich region was 
referred to as the G track. Chen and Manley show that a mutation in the BRE 
significantly increases general expression levels; however the activation potential of this 
promoter was the lowest of the promoters tested (Chen & Manley 2003). A mutation in 
the G track caused a modest reduction in general expression levels; however this 
promoter showed the greatest activation potential. 
1.1.3.2  Insulator sequences 
Insulator sequences can act as boundaries between euchromatin (transcriptionally 
active chromatin) and heterochromatin (transcriptionally inactive chromatin) preventing 
the spread of repressive chromatin structure (Sun & Elgin 1999). Insulators also show 
enhancer blocking activity; when an insulator sequence lies between an enhancer and a 
promoter, the interaction between those elements is prevented (Figure 1-1C) (Cai & 
Levine 1995; Kuhn & Geyer 2003). Insulator sequences can cause tertiary DNA 
structures, contain protein-binding sites and are associated with matrix attachment 
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regions (MARs) (Michel et al. 1993). These three findings could all influence chromatin 
structure and regulation of gene expression. However, when two gypsy insulator 
sequences are located between an enhancer and a promoter, the insulator function can 
be lost (Cai & Shen 2001). This pairing of insulators could result in activation of specific 
promoters by enhancers due to the specific chromatin structure, eg looping out, bringing 
the promoter and enhancer into close proximity (Maksimenko et al. 2008). Other 
insulator pairs do not show this loss of blocking activity (Kuhn et al. 2003). The study of 
insulator sequences has mainly been carried out using DrosoPhila as a model and 
although they are known to block enhancer activity, the mechanism is yet to be 
discovered. Insulators are known to contain protein binding motifs for example, CCCTC-
binding factor (CTCF) in all eukaryotes (Bell et al. 1999) and boundary element-
associated factor (BEAF) in DrosoPhila (Jiang et al. 2009). An insulator sequence has 
been identified in the proximal promoter of the spermatid-specific mouse gene, SP10 
which tethers the proximal promoter to the nuclear matrix in somatic cells and therefore 
represses transcription (Abhyankar et al. 2007). This demonstrates that insulator 
sequences can show similar functions in vertebrates as they do in DrosoPhila. Cohesin 
and CTCF play an important role in regulation of gene expression although the 
mechanisms have not yet been determined (Wendt & Peters 2009).  
Promoter targeting sequences have been found to act as anti-insulator sequences which 
allow enhancers to interact with specific promoters despite there being an insulator 
sequence between them (Sipos et al. 1998; Zhou & Levine 1999; Calhoun et al. 2002; 
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Calhoun & Levine 2003; Chen et al. 2005; Akbari et al. 2008). This mechanism, if it 
applies to a number of genes, has great potential to influence the specificity of 
enhancer-promoter interactions. 
1.1.3.3  Silencers 
Silencers are specific DNA sequences that act to repress transcription from a specific 
promoter (Figure 1-1C); they are considered the opposite of enhancers. 
1.1.4 Mechanisms of Enhancer-Promoter Interaction 
The three most common models for enhancer-promoter interaction over long distances 
are tracking, linking and looping and will be discussed in more detail in the following 
sections. 
Tracking 
Tracking involves transcription factors binding to enhancer sequences, which then scan 
the DNA until they reach a promoter and transcription is activated (Herendeen et al. 
1992). This model provides a possible mechanism of insulator sequences known to 
block enhancer activity when present between the enhancer and promoter. 
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Linking  
This model proposes that transcription factors binding to the enhancer induces the 
binding of proteins along the DNA between the enhancer and the promoter allowing their 
interaction (Bulger & Groudine 1999). A protein thought to be involved in this 
mechanism was identified in DrosoPhila, called Chip (Morcillo et al. 1996) . Chip-related 
proteins have since been identified in vertebrates (Morcillo et al. 1997); mouse Clim-1 
and -2 (Bach et al. 1997) and xenopus Xldb1 (Agulnick et al. 1996). These proteins are 
known to bind LIM (Lin-11, Isl-1 and Mec-3) domain-containing proteins but the precise 
functions in enhancer-promoter interaction facilitation are unknown. 
Looping 
This model suggests that protein-protein interactions occur between proteins bound to 
the enhancer and promoter-bound proteins with the DNA in between looping out (Bulger 
& Groudine 1999; Petrascheck et al. 2005). However, it has been shown that enhancer 
activity is position-independent in eukaryotes; this suggests there must be other 
mechanisms involved in facilitating the interaction. 
Interaction Specificity 
It was originally thought that enhancers were indiscriminate and would interact with any 
and all promoters within the locus. This idea came from enhancer trap methods where 
one promoter was combined with many enhancers in vivo (Weber et al. 1984; Wilson et 
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al. 1989). If this were true then all genes within the same genomic locus with a given 
enhancer would have the same expression patterns. The first example of enhancer-
promoter specificity was shown in DrosoPhila studying the causes of different 
expression patterns of gsb and gsbn found in the same locus (Li & Noll 1994). To date, 
many enhancer-promoter interactions have been studied and have been found to be 
specific. So far there have been several proposed mechanisms for enhancer-promoter 
specificity but it seems there is no single universal mechanism, as it is likely 
combinations of these models are working simultaneously (Sipos & Gyurkovics 2005). 
1.2  Mutations in cis-regulatory elements are involved in human 
disease 
Many developmental genes are known to have cis-regulatory elements that control their 
expression. There are a number of examples of genetic disorders caused by 
translocations of chromosomes or point mutations which affect a genes‟ cis-regulatory 
region and not the coding sequence. This emphasises the crucial role that cis-regulatory 
elements (for example enhancers) have during development. To understand the 
mechanism of promoter-enhancer interaction and the specificity of this interaction could 
greatly increase our knowledge of these genetic disorders. 
One example of a condition caused by a mutation in an enhancer is a rare syndrome 
affecting skeletal development and sex determination, campomelic dysplasia (CD). 
Mutations in the developmental gene SOX9 have been shown to cause cases of CD 
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(Foster et al. 1994) (Wagner et al. 1994). It has also been shown by several groups that 
certain forms of the disorder can result from chromosome translocations affecting cis-
regulatory elements and not alterations in the coding sequence of SOX9 itself (Wunderle 
et al. 1998) (Pfeifer et al. 1999).  
Similar DNA alterations have also been found in preaxial polydactyly patients, where a 
long range enhancer of the sonic hedgehog (SHH) gene (zone of polarising activity 
regulatory sequence (ZRS) enhancer) has a point mutation causing abnormal 
expression of the SHH developmental regulator (Gurnett et al. 2007). A case has been 
described where a translocation breakpoint lies within the fifth intron of the LMBR1 gene 
(the location of the ZRS enhancer) in a patient with preaxial polydactyly (Lettice et al. 
2002).  
Aniridia is the absence of an iris and is thought to be caused by loss of one copy of the 
PAX6 gene, Fantes and colleagues identified 2 patients with translocations that did not 
affect the PAX6 gene itself. They suggested that this could be due to positional effects 
possibly affecting long distance cis-regulatory elements (Fantes et al. 1995). 
Little is known about the mechanisms of interaction of enhancers and promoters and 
even less about the specificity of these interactions therefore warranting further study. 
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1.3 Zebrafish as a model organism 
Zebrafish has been established as a great model for a wide variety of genetics 
experiments, these are discussed below. There are many advantages of using this 
model organism, including; external development of embryos, transparency of embryos, 
fully sequenced genome, relatively rapid development and the production of hundreds of 
embryos from a single crossing of an adult pair. Between 100 and 200 fertilised eggs 
can be collected from each pair of adult fish every week. This allows large scale 
experiments to be carried out on large numbers of embryos. The external development 
and transparency of the embryos allows the study of the development of organ systems 
during early development (Glass & Dahm 2004). It also allows the use of fluorescent 
reporters used to test putative enhancer sequences in vivo (Iklé et al. 2012). 
Other methods used in genetics utilising this model include: morpholino gene knock-
down (Nasevicius & Ekker 2000); targeted, germline genome mutagenesis using 
transcription activator-like effector nucleases (TALENs) (Dahlem et al. 2012; Bedell et al. 
2012); disease modelling (Berman et al. 2003; Gama Sosa et al. 2012); behavioural 
genetics in adult fish (Norton & Bally-Cuif 2010); and screens for novel drugs 
(Langheinrich et al. 2002; Langheinrich 2003). 
There are also many online resources aiding researchers using the zebrafish model. 
These include: zfin – The Zebrafish Model Organism Database (Sprague et al. 2001); 
Ensemble – a source of the annotated human, mouse and zebrafish genomes (Flicek et 
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al. 2012); CONDOR – an online database of conserved non-coding elements (CNEs) 
(Woolfe et al. 2007); and UCSC (University of California Santa Cruz) Genome Browser – 
allows convenient visualisation of genomes of a number of species (DiBiase et al. 2006).  
1.3.1 Zebrafish development 
In 1995 a paper was published detailing the developmental stages of zebrafish larvae up 
until 5 days post fertilisation (dpf) (Kimmel et al. 1995). This provides the information on 
all of the nomenclature used to describe development in the zebrafish larvae. Zebrafish 
development is far more rapid than other vertebrates; all major organs develop within 
the first 3 dpf and so these can easily be visualised while the embryo is still transparent. 
It also means that a sexually mature fish can be grown from fertilisation within around 3-
4 months (Westerfield 2000), making transgenic zebrafish work much quicker than in 
mouse, for example. 
1.3.2 Uses of zebrafish transgenesis 
Transgenesis is a widely used method in zebrafish research and it is used for a number 
of types of study. For example, zebrafish transgenesis is used in tissue-labelling and in 
vivo imaging (Gilmour et al. 2002), disease-modelling (Langenau et al. 2005), the study 
of regulatory DNA (Kenyon et al. 2011) and the study of gene function (Min et al. 2012). 
Due to the popularity of transgenesis methods across the zebrafish research community, 
it is vital to optimise these methods to allow more research to continue. 
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1.4 Transgenesis technologies 
A transgenic organism is one in which the deoxyribonucleic acid (DNA) sequence has 
been permanently altered by insertion of a foreign sequence of DNA. The original 
method of making transgenic zebrafish was by injecting linearised DNA into early 
embryos which can lead to concatemerisation of these fragments and integration into a 
chromosome in a random location (Stuart et al. 1988). More recent transgenesis 
methods utilise various transposon systems to integrate a single copy of a transgene 
into a random position in the genome. Examples include the P element transposon in 
DrosoPhila (Rubin & Spradling 1982) and other transposons in vertebrate models 
(Hogan et al. 1982; Kawakami et al. 1998). This involves cloning the transgene into a 
vector containing transposon arms (recognition sites) that facilitate the integration of the 
DNA sequence between them. In vertebrate models, including zebrafish, the mRNA of 
the transposase (enzyme that facilitates transposition) is co-injected with the DNA 
containing the transgene flanked by transposon arms into early embryos. The transgene 
becomes integrated into the genome in a proportion of cells. If the transgene is present 
in the gametes of the organism it can be passed on to some of it‟s offspring which will 
contain the transgene in all cells. 
1.4.1 Transposons – SB and Tol2 
Sleeping Beauty (SB) is a synthetic transposon system developed from inactive 
transposons of the Tc1/ mariner superfamily found in teleost fish genomes (Ivics et al. 
1997). SB has been shown to function in mice (Luo et al. 1998), human cells (Ivics et al. 
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1997) and in zebrafish (Davidson et al. 2003). This system was found to increase 
transposition efficiency from 5 % to 31 % compared to standard plasmid micro-injection 
transgenesis techniques in zebrafish (Davidson et al. 2003). 
The Tol2 gene was found in the genome of the teleost fish, medaka, and is from the hAT 
(hobo, Activator, Tam3) family of transposases (Koga et al. 1996). The Tol2 transposon 
system has been known to give transgenesis efficiencies of up to 50% compared to 
approximately 5-10% for the previous methods of micro-injecting plasmid DNA (Urasaki 
et al. 2006). This involves cloning Tol2 recognition sites either side of the DNA 
sequence to be integrated and then co-injecting this construct with Tol2 transposase 
mRNA (Urasaki et al. 2006). The efficiency of inheritance of the transposon by progeny 
of transgenic zebrafish was also greatly increased (Kawakami, Takeda, et al. 2004). It 
has been tested in zebrafish (Kawakami et al. 1998), mice (Kawakami & Noda 2004) 
and xenopus cells (Kawakami, Imanaka, et al. 2004). The Tol2 transposon system was 
shown to facilitate single copy transposition (by a cut and paste mechanism) as opposed 
to the numerous copies (20-100) observed using the SB system (Urasaki et al. 2008). 
The Tol2 transposon system is now widely used in zebrafish transgenesis for such 
purposes as the generation of stable transgenic lines, enhancer traps and transient 
expression assays (Kawakami 2007).  
These transposon systems allowed much more efficient transgenesis of several model 
organisms. However, a disadvantage of using transposon systems is that integration into 
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the genome is random and so positional effects can vary greatly between the same 
construct injected into different embryos.  
1.4.2 Site-specific reversible recombinases – Cre and Flp 
To overcome the problem of variable position effects due to random integration, site-
specific integration methods have been studied as a way of integrating different 
transgenes into the same locus in the genome. Cre and flippase (Flp) are two well-
known site-specific phage recombinases and have been used in transgenesis methods. 
Cre recombinase and Flp mediate site-specific recombination between loxP and FRT 
sites respectively. Cre and Flp are both part of the tyrosine recombinase family. The 
mechanism involves cleavage of a single strand of DNA in the middle of two palindromic 
sequences of the loxP site and ligation occurs between swapped strands of DNA in 
another cleaved loxP site resulting in the formation of the Holliday junction (Hoess & 
Abremski 1985). This homologous recombination can be visualised in Figure 1-4 which 
shows the intermediates involved in the recombination between two loxP sites. 
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Figure 1-4 Mechanism of recombination between loxP sites catalysed by Cre 
Schematic showing the steps and intermediates involved in recombination between two loxP sites during 
Cre-mediated reactions. Single strands of both loxP sites are cleaved and are ligated together after strand 
exchange. Isomerisation then takes place before the other strands are cleaved and ligated together after 
strand exchange. Figure adapted from (Gopaul et al. 1998) 
Cre and Flp have been used to integrate two different transgenes into the same 
genomic locus in DrosoPhila (Siegal & Hartl 1996). This was done by cloning two 
transgenes between transposon arms; one flanked with loxP sites and the other with 
FRT sites. The construct was then injected into DrosoPhila embryos to make a 
transgenic line. Excision of either of the transgenes could then be induced using either 
Cre or Flp. This method has also been used for co-placement of two transgenes in the 
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mouse genome (Tanimoto et al. 2008). This method has limitations though; as only two 
transgenes can be compared in the same genomic position and each pair of sister lines 
will have a different transgene location. 
1.4.3 Site-specific irreversible recombinase – ϕC31 integrase 
More recently the possibility of using an integrase from the C31 phage has been 
studied. The C31 integrase facilitates the synapse of attP and attB integration sites, the 
natural function being to integrate the phage genome into the bacterial host genome 
(Kuhstoss & Rao 1991).  
PhiC31 integrase is part of the serine recombinase family which have a different 
mechanism of recombination than the tyrosine recombinases described above. PhiC31 
integrase binds to two recognition sites, attP and attB, and cleaves all four DNA strands 
simultaneously leaving a staggered break. Covalent bonds are formed between the 5‟ 
DNA end and the integrase; one half of the complex then rotates 180° relative to the 
other and re-ligation of the strands occurs (Smith et al. 2004). 
The recombination between attP and attB sites in a foreign organism was first 
investigated in Escherichia coli (Thorpe & Smith 1998). PhiC31 integrase was shown to 
be directional due to the non-identical recognition sites. The recombination of attP and 
attB by PhiC31 integrase was also shown to occur in vitro proving that no co-factors 
were required (Thorpe & Smith 1998). Excision of DNA by recombination was shown to 
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work efficiently (>50%) in human cell lines transfected with a PhiC31 integrase 
expression vector containing attP and attB (Groth et al. 2000). In 2004, PhiC31 integrase 
was used to target integration of a donor vector containing attB into an attP-containing 
transgenic DrosoPhila line genome (Figure 1-5) (Groth et al. 2004). 
 
Figure 1-5 Strategy to target integration of a donor vector into the genome of a transgenic 
DrosoPhila embryo 
A transgenic DrosoPhila recipient line was made using P element transposon to introduce an attP target 
site into the genome. Injection of the donor vector into recipient line embryos resulted in the integration of 
the whole vector into the attP site. Figure adapted from (Groth et al. 2004) 
A different strategy was employed in mice which showed that recombination-mediated 
cassette exchange could target a transgene in a donor vector to the target site of a 
transgenic recipient line mouse (Belteki et al. 2003). This involved using pairs of inverted 
attP sites in the recipient line and pairs of inverted attB sites flanking the transgene in 
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the donor vector. The integration of a donor vector into a target site of a transgenic 
mouse was shown to be inherited in the germline. An RMCE transgenesis system has 
also been developed in DrosoPhila which utilises PhiC31 integrase (Figure 1-6) 
(Bateman et al. 2006).  
 
Figure 1-6 PhiC31 integrase transgenesis in DrosoPhila 
Schematic showing the targeted integration of a donor vector into the genome of a transgenic fruit fly. 
Within the genome of the transgenic fly there is mini-white gene flanked by inverted attP sites. The donor 
vector contains yellow gene flanked by inverted attB sites. During recombination-mediated cassette 
exchange, an intermediate is formed. Figure from (Bateman et al. 2006) 
Since starting this project, the study of PhiC31 integrase use in zebrafish has been 
published. In 2010, Lister published a paper showing that PhiC31 integrase can facilitate 
intramolecular excision of a DNA sequence flanked by an attP site and an attB site 
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(Figure 1-7). Excision was also shown to occur in the genome of a stable transgenic line 
when embryos were injected with PhiC31 integrase RNA. Lister later showed that PhiC31 
integrase-mediated excision could be restricted to specific tissues (Lister 2011). 
 
Figure 1-7 Integrase facilitates recombination between attB and attP in zebrafish 
(A) Injection of the depicted DNA construct alone results in GFP expression in the zebrafish. (B) Co-
injection of the DNA construct and PhiC31 integrase RNA results in intramolecular excision of GFP 
resulting in mosaic expression of both GFP and DsRed. Figure adapted from (Lister 2010). 
An RMCE strategy has also been developed in zebrafish (Figure 1-8) (Hu et al. 2011). 
Firstly, a recipient transgenic line was made containing a cFos promoter sequence 
upstream of a GFP sequence that were flanked by attP sites. Upstream of the 5‟ attP 
site was a Sox10 enhancer driving expression in a number of tissues including the 
spinal cord. When the donor construct containing attB and mCherry was co-injected into 
transgenic embryos, RMCE occurred and mCherry was observed showing an 
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expression pattern consistent with Sox10. This showed that targeted integration into the 
genome of a transgenic zebrafish was possible.  
 
Figure 1-8 Strategy for recombination-mediated cassette exchange in zebrafish 
This figure is from (Hu et al. 2011) and shows the strategy employed for targeted recombination-mediated 
cassette exchange facilitated by PhiC31 integrase in zebrafish. 
There are natural-occurring att sites in vertebrate genomes, for example, two have been 
identified in the mouse genome (Thyagarajan et al. 2001) and several in the DrosoPhila 
genome (Groth et al. 2004). These sites, termed „pseudo-attP‟ sites, may be recognised 
by integrase and cause integration at these loci. 
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1.4.4 Use of BACs in transgenesis 
Due to their ability to hold very large sequences of DNA, bacterial artificial chromosomes 
(BACs) have become a very useful tool in many areas of research. They have been 
shown to provide rescue of knock-down phenotypes in transgenic mice due to the 
endogenous control of the rescue gene contained within the BAC (Antoch et al. 1997). 
Linearised BACs have been used to make transgenic mice (Chrast et al. 1999) and 
more recently, Tol2 has been used to increase efficiency of BAC transgenesis in mice 
and zebrafish (Suster et al. 2009). The increase in fully sequenced genomes has 
resulted in BAC libraries being widely available and easily obtainable (Vintersten et al. 
2008) and so the BAC has become a popular tool in genetic studies. BACs are also 
used in disease modelling, in 2003 a Down syndrome model mouse was published 
using BAC transgenesis (Kazuki et al. 2003).  
BACs can be used to study cis-regulatory elements as their large size allows the 
integration of a whole genomic locus encompassing all cis-regulatory elements (Jessen 
et al. 1999). BACs can also be modified to insert a fluorescent reporter sequence 
immediately upstream of the translational start site of the gene of interest (Heintz 2001; 
Yang et al. 2006). This allows the visualisation of the reporter gene driven by an 
endogenous promoter accompanied by all of the cis-regulatory elements which is 
expected to recapitulate endogenous expression patterns precisely which cannot be 
achieved when studying cis-regulatory elements as a solitary unit. 
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1.5 Aims and objectives 
A study has not yet been carried out studying enhancer-promoter specificity in vivo 
within the endogenous genomic locus. It seems likely that a combination of all described 
mechanisms of specificity result in the differential gene regulation of the vast number of 
genes in the eukaryotic genomes. We know that the study of gene regulation is essential 
to understand many genetic disorders and the amount of research in this area reflects 
that. 
The aim of this project was to develop a transgenesis system that would allow the study 
of enhancer-promoter interactions within their genomic environment. The zebrafish was 
selected as it is the ideal animal model for this type of experiment as the embryos are 
transparent and fluorescent reporters can be used to visualise expression patterns 
driven by cis-regulatory DNA.  
In order to carry out such an experiment, a number of techniques needed to be 
developed. Firstly, in order to alleviate variability in position effects when studying a 
transgene integrated randomly into the zebrafish genome, a targeted integration system 
was developed. PhiC31 integrase is used frequently in DrosoPhila transgenesis and has 
been shown to function in mammalian cells. This led us to hypothesise that it would also 
work in zebrafish and allow us to target transgene integration into the same genomic 
locus resulting in consistent position effects between different constructs. The 
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development of a PhiC31 integrase system in zebrafish will be useful in any experiments 
where subtle changes in gene expression will affect the results. 
In vertebrate genomes, long-range enhancers are known to be located up to 1 MB away 
from their target gene. In order to study such enhancers, both target gene and enhancer 
must be present in the same DNA construct as well as intervening DNA that may contain 
other regulatory DNA essential for endogenous expression; for example insulators. This 
is just not possible using standard vectors and so BAC transgenesis needs to be 
employed to allow long-range enhancers to be studied. The modification of the BACs to 
introduce fluorescent reporter genes to label the target gene expression pattern will 
allow a visual read out of enhancer interactions with the target promoter. 
To be able to target the integration of a modified reporter-containing BAC into the same 
position in the genome would enable the study of enhancer-promoter interactions in 
vivo. The BAC could then be mutated in specific locations thought to be involved in 
enhancer-promoter specificity; for example specific motifs of the core promoters. To 
understand the mechanisms by which enhancers can interact with specific promoters 
would be extremely useful in the study and treatment of genetic disorders involving cis-
regulatory DNA. 
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2 MATERIALS AND METHODS 
2.1 Materials 
All chemicals described throughout were obtained from Sigma-Aldrich (Poole, UK) 
unless otherwise stated.  
2.1.1 Molecular Biology 
Pfu polymerase Promega, Southampton, UK 
PCR extender 5prime, Nottingham,UK 
Oligonucleotides Sigma-Aldrich, Poole, UK 
Agarose Bioline Reagents, London, UK 
DNA ladder 1 kb New England Biolab, Hitchin, UK 
DNA ladder 100 bp New England Biolab, Hitchin, UK 
6x gel loading dye New England Biolab, Hitchin, UK 
Go taq polymerase Promega, Southampton, UK 
dNTPs (deoxynucleotides) Fisher Scientific, Loughborough 
Restriction enzymes New England Biolab, Hitchin, UK 
Triton-X-100 Sigma-Aldrich, Poole, UK 
T4 DNA ligase Promega, Southampton, UK 
T4 DNA polymerase Promega, Southampton, UK 
Phenol Sigma-Aldrich, Poole, UK 
Phennol:Chloroform Sigma-Aldrich, Poole, UK 
ECL+ (enhanced 
chemiluminescence) 
GE Healthcare 
2.1.2 Antibodies 
Anti-Bacteriophage PhiC31 
Integrase antibody 
Abcam, Cambridge, UK 
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Secondary Abcam, Cambridge, UK 
2.1.3 Bacterial Culture 
Luria Broth (LB) Sigma-Aldrich, Poole, UK 
LB agar Sigma-Aldrich, Poole, UK 
Ampicillin Sigma-Aldrich, Poole, UK 
Kanamycin Sigma-Aldrich, Poole, UK 
Tetracycline Sigma-Aldrich, Poole, UK 
Chloramphenicol Sigma-Aldrich, Poole, UK 
Chemical competent cells Bioline Reagents, London, UK 
  
2.1.4 Kits 
NucleoSpin plasmid Camlab Ltd, Cambridge, UK 
NecleoSpin gel and PCR clean up kit Camlab Ltd, Cambridge, UK 
NucleoBond Xtra Midi Camlab Ltd, Cambridge, UK 
NecleoBond BAC 100 Camlab Ltd, Cambridge, UK 
mMessage machine SP6 Ambion, Warrington, UK 
Blunt cloning Clontech, France 
2.1.5 Zebrafish work 
Phenol Red Solution Sigma-Aldrich, Poole, UK 
Microfiltration columns  Pall, Ann Harbor, USA 
Proteinase K Sigma-Aldrich, Poole, UK 
Gentamycin Fisher Scientific, Loughborough 
1-phenyl 2-thiourea (PTU) Sigma-Aldrich, Poole, UK 
Protease (Streptomyces griseus) Sigma-Aldrich, Poole, UK 
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2.1.6 Zebrafish lines 
The zebrafish used in this project were AB* wild type strain. 
2.1.7 Consumables 
Standard laboratory consumables for example Eppendorf and Falcon tubes are not 
included here. 
Microloader tips Eppendorf 
Nuclease-free water Sigma-Aldrich, Poole, UK 
X-ray film Kodak 
2.1.8 Equipment 
PCR machine GeneFlow Lab cycler 
Agarose gel tanks Bio-Rad 
Stereomicroscope SMZ645  Nikon, Kingston, UK 
Digital microscope camera DFC300 FX  Nikon, Kingston, UK 
Centrifuge Thermo Scientific, Loughborough, UK 
Nanodrop Thermo Scientific, Loughborough, UK 
Microfuge Thermo Scientific, Loughborough, UK 
Bacterial incubator Thermo Scientific, Loughborough, UK 
Embryo incubator Thermo Scientific, Loughborough, UK 
Waterbath Fisher Scientific, Loughborough 
Temperature block/shaker Eppendorf Thermomixer 
Gas microinjector Tritech Research, Los Angeles, USA 
Flaming‐Brown needle puller  Sutter Instruments, Novato, USA 
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2.1.9 Solutions 
TBE buffer 
90 mM Tris base, 90 mM Boric acid, 2 mM EDTA (Ethylenediaminetetraacetic acid), pH 
8 
E3 medium 
5 mM NaCl, 0.17 mM KCl, 0.33 mM CaCl2, 0.33 mM MgSO4, gentamycin 
DNA extraction buffer 
0.1 M Tris pH9, 0.1 M NaCl, 0.05 M EDTA, 0.2 M Sucrose, 0.5 % SDS (Sodium dodecyl 
sulfate), 750 µg/ml Proteinase K 
PTU 
0.0045% PTU in 1 x E3 medium 
SDS sample buffer 
63 mM Tris-HCl pH 6.8, 10% glycerol, 5% ß-mercaptoethanol, 3.5% sodium dodecyl 
sulphate 
SDS running buffer 
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192 mM Glycine, 250 M Tris-Base and 0.1% SDS 
Transfer buffer 
192 mM Glycine, 250 mM, Tris-Base and 20% methanol 
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2.2 Methods 
2.2.1 Molecular Techniques 
2.2.1.1 Molecular Cloning 
Polymerase Chain Reaction (PCR) 
The primers were diluted to 10 M in a volume of 50 l: 5 l forward primer, 5 l reverse 
primer and 40 l nuclease-free water. The PCR reaction was set up as follows: 
Reagent Volume 
Nuclease-free water 326 l 
10 x buffer 40 l 
10 mM dNTPs 8 l 
10 M forward and reverse primer mix 20 l 
DNA template (200 ng/µl) 2 l 
Pfu I enzyme (1 unit/ µl) 4 l 
Total reaction volume 400 l 
 
The PCR machine was then programmed as follows: 
Temperature Time 
94 °C 2 min 
94 °C 30 sec 
60 °C 1 min 
72 °C 2 min 
72 °C 5 min 
12 °C Hold 
35 cycles 
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The annealing temperature (60 °C) and extension time are variable depending on the 
primers used and the length of the PCR fragment respectively. Any alterations made are 
described in the text below. If the PCR product was too long to use Pfu polymerase, the 
PCR extender system (5prime) was used instead. 
Electrophoresis gel 
To make a 1 % agarose gel to separate DNA of different sizes; 1 g of agarose powder 
was dissolved per 100 ml of 1 x Tris-borate-EDTA (TBE) buffer. This was heated until 
the agarose dissolved and allowed to cool to 50-60 °C. Five µl of ethidium bromide was 
added and the agarose poured into a gel tray containing a comb and allowed to solidify. 
This was then transferred to an electrophoresis tank containing 1 x TBE buffer and the 
comb was removed. As a marker, 5 µl of New England Biolab 1 kb or 100 bp DNA 
ladder were loaded onto the gel. Loading dye was added to the samples (1 µl per 5 µl of 
sample) which were then loaded onto the gel. The tanks were connected to a power 
pack set at 80-90 V and ran for 30-60 minutes depending on the amount of separation 
required. 
Gel extraction 
To isolate the PCR fragment, the Machery-Nagel NucleoSpin gel and PCR clean-up kit 
was used. Firstly, DNA loading dye (Promega) was added to the PCR reaction and it 
was run on a 1 % agarose gel. The appropriate DNA band was then cut out using a 
Ultra Violet (UV) illuminator and excess agarose was removed. The agarose containing 
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the DNA was then weighed and dissolved in NTI buffer at a ratio of 200 l to 100 mg of 
agarose. This was heated to 60 °C on a shaker to allow the agarose to dissolve and 
then cooled on ice. The solution was transferred to a column and incubated at room 
temperature for 1 minute. The column was centrifuged at 15,000xg for 1 minute. The 
flow through was discarded and 700 µl of buffer NT3 was added to the column and the 
centrifugation was repeated. Again the flow through was discarded and the wash step 
repeated with 500 µl of buffer NT3. The flow through was discarded and the column was 
centrifuged for 2 minutes to dry the membrane. The column was transferred to a sterile 
1.5 ml Eppendorf tube and 30 µl of nuclease-free water was added to the column and 
incubated at room temperature for 1 minute. The tubes were centrifuged at 15000xg for 
1 minute and the column was discarded. The eluate was stored at -20 °C.  
Enzyme digests and gel extraction 
Enzyme digest reactions were assembled as follows: 
Reagent Amount 
Nuclease-free water Up to 50 µl 
Appropriate restriction enzyme buffer 5 µl 
DNA (vector or PCR product) 10 µg or 5µg 
Bovine Serum Albumin (BSA) 0.5 µl 
Restriction Enzyme 10 units 
Total reaction volume 50 µl 
 
44 
 
The digests were incubated for 2 hours at 37 °C. The DNA was then separated on a 1% 
agarose gel and the appropriate fragments purified as described above. 
Ligation reaction 
The ligation reactions were assembled as follows: 
Reagent Amount 
Nuclease-free water Up to 20 µl 
Ligase buffer 2 µl 
Vector DNA 100 ng 
Insert DNA Molar ratio 3 insert:1 vector 
T4 DNA ligase 1 µl 
Total reaction volume 20 µl 
The ligation reaction was incubated at 16 °C overnight. 
Transformation 
The ligation reaction was then used to transform chemical competent E. coli cells by 
adding 10 l of the ligation reaction mixture to 50 l cells (incubated on ice for 15 mins) 
and heat shocking at 42 C for 45 secs. Subsequently, 400 l of LB media was added to 
the cells and they were incubated on a shaker at 37 C for 30 – 60 minutes. The 400 l 
was then spread on an LB agar plate with an antibiotic selection appropriate for the 
vector. The plates were then incubated at 37 C overnight and checked for colonies the 
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next day. Colonies from each plate were picked and used to inoculate 5 ml LB medium. 
These cultures were grown overnight at 37 C and 220 rpm (revolutions per minute). 
Minipreps 
To isolate the plasmid DNA from the bacterial cultures, the Machery-Nagel Nucleospin 
plasmid kit was used. The bacteria were pelleted by centrifugation at 10,000xg for 1 
minute. The supernatant was discarded and the bacterial pellet was re-suspended in 
250 l of Buffer A1. Next, 250 l of Buffer A2 was added and the tube was inverted 
gently 4-6 times. This was then left for approximately 3 or 4 minutes for the lysate to 
clear. After this time, 300 l of Buffer A3 was added and the tube inverted gently 4-6 
times. The bacterial lysate was the centrifuged at maximum speed (15,000xg) in a 
microcentrfuge for 10 minutes. The supernatant was transferred to a Spin Column set up 
in a 2 ml Collection Tube and this was centrifuged at 15,000xg for 1 minute. The flow 
through was discarded and the Spin Column was replaced in the Collection Tube; 600 l 
of Buffer A4 was added to the Column and it was centrifuged again at 15,000xg for 1 
minute. The flow through was discarded and the Column was centrifuged for another 
minute at maximum speed to dry the membrane. The Column was then transferred to a 
1.5 ml Eppendorf tube and 50 l of nuclease-free water was added to the column. This 
was incubated at room temperature for 1 minute and then centrifuged at 15,000xg for 1 
minute. The column was then discarded and the eluted DNA was stored at -20 C. 
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Test enzyme digests 
A sample of the miniprep DNA was digested using two or three restriction enzymes to 
ensure the PCR product had ligated into the vector as expected. They were set up as 
follows: 
Reagent Amount 
Nuclease-free water Up to 20 µl 
Appropriate buffer 2 µl 
BSA 0.2 µl 
Appropriate enzyme(s) 2 – 3 units 
Total reaction volume 20 µl 
The digests were incubated at 37 °C for 2 hours, and the reaction was run on a 1 % 
agarose gel to check the correct band sizes were present. 
Sequencing 
Vector sequencing was carried out externally by Beckman Coulter Genomics. The 
plasmid samples were prepared by diluting the sample to 100 ng/µl and oligonucleotides 
were diluted to 5 µM. 
The results were analysed by aligning the sequencing data with the known sequence of 
the insert sequence and checking for any differences. This analysis was carried out 
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using the software SerialCloner and when required, Cap3 sequence assembly program 
available online (http://pbil.univ-lyon1.fr/cap3.php). 
Midipreps 
Firstly, a 100 ml culture was set up and incubated overnight at 37 °C and 220 rpm. The 
next day the cells were harvested by centrifugation at 6000xg and 4 °C for 20 minutes. 
The supernatant was discarded and the pellet resuspended in 8 ml of Resuspension 
Buffer + RNase A (ribonuclease). Then, 8 ml of Lysis Buffer was added and the tube 
inverted gently 4-6 times. This was left at room temperature for 3-4 minutes before 
adding 8 ml of Neutralisation Buffer. The lysate was cleared by centrifugation at 6000xg 
and 4 °C for 10 minutes and then the supernatant was decanted into the column filter. 
Once all of the solution had passed through the filter and column, 5 ml of Equilibration 
Buffer was added to wash out the lysate in the filter. The filter was then removed and 8 
ml of Wash Buffer was added to the column. After flow through of the Wash Buffer, the 
column was placed in a 50 ml Falcon tube and 5 ml of Elution Buffer was added. The 
column was then discarded and 3.5 ml of isopropanol was added to the eluate. This was 
mixed by inverting the tube and then centrifuged at 15,000xg and 4 °C for 30 minutes. 
The supernatant was removed and 5 ml of 70 % ethanol was added to the pellet. 
Centrifugation was repeated and the ethanol removed. The pellet was allowed to air dry 
completely before resuspension in 500 µl of nuclease-free water. 
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Determination of nucleic acid concentration 
The concentration of nucleic acid solutions were measured using the Nanodrop 
spectrophotometer. The absorption at a wavelength of 260 nm was measured to 
determine nucleic acid concentration. Absorption ratios of 260/280 nm and 260/230 nm 
were checked to ensure there were no contaminants (proteins or ethanol) that would 
affect downstream protocols. 
2.2.1.2 In vitro Transcription 
Five micrograms of the appropriate pCS2+ vector was linearised downstream of the 
polyA tail with NotI restriction enzyme. A 50 µl digest was set up containing 5 µl of NEB 
buffer 4, 0.5 µl BSA, 5 µg plasmid DNA, 5 units NotI and made up to a total of 50 µl with 
nuclease-free water. The reaction was incubated for 2 hours at 37 °C and the DNA was 
separated on a 1 % agarose gel. The DNA was then isolated using the Machery-Nagel 
Gel and PCR clean up kit and eluted in 50 µl nuclease-free water. The in vitro 
transcription reaction was set up as follows: 
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Reagent Amount 
Nuclease-free water Up to 60 µl 
2x NTP/CAP 30 µl 
10x reaction buffer 6 µl 
Linear DNA template 3 µg 
Enzyme 6 µl 
Total reaction volume 60 µl 
This was incubated at 37 °C for 2 hours. Next, 3 µl of TURBO DNase was added and 
the reaction was incubated for a further 15 minutes at 37 °C. In order to stop the 
reaction, 345 µl of nuclease-free water and 45 µl of Ammonium Acetate Stop Solution 
were added and the solution was mixed gently. The Ribonucleic Acid (RNA) was 
extracted by adding 450 µl of phenol:chloroform and mixing. The phases were then 
separated by centrifugation at 15,000 xg for 20 minutes and the aqueous phase was 
removed and transferred to a fresh tube. An equal volume of chloroform was added and 
the solution mixed. The centrifugation was repeated and the top phase was transferred 
to a fresh tube. The RNA was then precipitated by adding 0.2 volumes of 5 M 
ammonium acetate and 2 volumes of 100 % ethanol. The RNA was pelleted by 
centrifugation at 15,000 xg for 30 minutes at 4 °C. The supernatant was removed and 
discarded, 500 µl of 75 % ethanol was then added and the centrifugation was repeated. 
The supernatant was discarded and the pellet was allowed to air-dry for 5-10 minutes. 
The RNA was then resuspended in 50 µl nuclease-free water and stored at -80 °C.  
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2.2.2 Zebrafish Embryo Manipulation 
2.2.2.1  Microinjections 
The day prior to injections, pairs of zebrafish were set up in cages, separated by a 
divider. The morning of injections the divider was removed and the embryos were 
collected after 10 minutes. The embryos were injected with the injection solution (50 
ng/µl DNA construct, 15 ng/µl Tol2 RNA (where required), 1 x phenol red solution and 
1% rhodamine (where required)) and incubated at 28 °C in water from the fish system. 
The afternoon after the injections the water was replaced with E3 medium supplemented 
with Gentamycin. The embryos were incubated at 28 °C for up to five days. Fish that 
were to be grown up were transferred to the zebrafish facility on day 5 and feeding was 
started. 
2.2.2.2 Genomic DNA Isolation 
Ten – twenty 5 dpf embryos from the same pair crossing were pooled and transferred to 
a 1.5 ml Eppendorf tube, as much liquid was removed as possible and 770 µl of DNA 
extraction buffer was added depending on the number of embryos. The samples were 
then vortexed briefly and incubated for 2 – 3 hours at 55 °C until digestion was 
completed. The samples were then heated to 95 °C for 10 minutes to inactivate the 
Proteinase K. Samples were centrifuged at 8000 rpm for ≥10 minutes to remove any 
debris, the supernatant was transferred to a fresh tube and stored at -20 °C. When 
required, 2 µl of the DNA was added to a 25 µl PCR reaction. 
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2.2.2.3  Imaging 
The zebrafish embryos were imaged using a Nikon SMZ1500 fluorescence 
stereomicroscope for both bright field and fluorescence images. The imaging software 
used was NIS elements. 
2.2.2.4 Western Blotting 
Protein samples were extracted from zebrafish embryos and Sodium Dodecyl Sulphate 
PolyAcrylamide Gel Electrophoresis (SDS-PAGE) was employed to separate proteins by 
size. This protein separation was then transferred onto a nitrocellulose membrane which 
was subsequently blotted with primary and secondary antibodies to label specific 
proteins of interest. 
Sample Preparation 
Embryos between 2 and 4 cell stage were dechorionated using a pronase solution. As 
the first couple of embryos are dechorionated, the whole dish is rinsed 3 times each time 
in a litre of fish water (2 parts tap water and 1 part deionised water). After 
dechorionation, the embryos are kept in an agarose lined petri dish. When the embryos 
reached high stage the yolk was removed from 20 embryos using a hypodermic needle 
and the cells were transferred to a 1.5 ml Eppendorf tube. As much of the liquid was 
removed as possible and 150 µl of SDS sample buffer was added. The cells were 
homogenised thoroughly using a pestle until the solution was uniform. This solution was 
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then incubated in a waterbath at 100 °C for 5 minutes and centrifuged at 15,000xg for 2 
minutes. The supernatant was transferred to a fresh Eppendorf tube. 
SDS-PAGE 
The 10 % SDS polyacrylamide resolving gel was made as follows: 
Reagent Amount 
Acrylamide 3.4 ml 
Water 3.8 ml 
1.5 M Tris-HCl pH 8.8 2.5 ml 
10 % Ammonium persulfate 200 µl 
10 % SDS 100 µl 
TEMED 
(Tetramethylethylenediamine) 
10 µl 
Total volume ~10 ml 
This was then immediately pipetted into 1 mm glass plates. Isopropanol was added 
slowly to the top of the gel and it was allowed to set. Once the resolving gel had set, it 
was rinsed thoroughly to remove the isopropanol. The stacking gel was made as follows: 
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Reagent Amount 
Acrylamide 1 ml 
Water 3.4 ml 
1.5 M Tris-HCl pH 8.8 1.5 ml 
10 % Ammonium persulfate 90 µl 
10 % SDS 60 µl 
TEMED 5 µl 
Total volume ~6 ml 
This was pipetted on top of the resolving gel, a comb was immediately added and it was 
allowed to set. 
Sample loading buffer was added to the protein samples and they were incubated at 
100 °C for 5 minutes. A protein molecular weight ladder was loaded into the first well 
followed by the samples in subsequent wells. The gel was run in SDS running buffer for 
1-2 hours at 100 V. 
Transfer 
The transfer apparatus was prepared as depicted in Figure 2-1. The sponge, membrane 
and filter paper were all soaked in transfer buffer prior to preparation. 
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Figure 2-1 Layout of materials required for protein transfer 
Figure from Abcam Western Blot Protocol 
(http://www.abcam.com/index.html?pageconfig=resource&rid=13045) 
The transfer is run for an hour and to prevent over-heating, an ice pack is placed in the 
transfer buffer. 
Immunoblotting 
The membrane was blocked in 10 % dried milk powder (Marvel) dissolved in Tris 
buffered saline (1xTBS) at 4 °C overnight on a roller. The primary and secondary 
antibodies were diluted in 10 % dried milk powder. After blocking overnight, the diluted 
antibody was added and the membrane was incubated at room temperature for 1 hour 
on a roller. The membrane was then washed for 5 minutes in PBST and this step was 
repeated 3 times. The membrane was blocked again in 10 % dried milk powder for 5 
minutes at room temperature on a roller. The diluted secondary antibody was then 
added and incubated for 1 hour at room temperature after which the wash steps were 
repeated as above. The membrane was then incubated with enhanced chemo-
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luminescence plus (ECL+) following manufacturer‟s guidance (GE Healthcare) for 5 
minutes. The bands were visualised using X-ray film which was developed. 
2.2.3 Making a Transgenic Line 
The following describes the steps taken to make a stable transgenic zebrafish line.  
Firstly, approximately 200 embryos were co-injected with the DNA construct containing 
the desired transgene flanked by Tol2 arms and Tol2 transposase mRNA. These were 
incubated in E3 medium supplemented with gentamycin at 28.5 °C for 5 days in an 
incubator. Each day, the embryos were observed under a fluorescence 
stereomicroscope. The healthy looking embryos were selected and taken to the 
zebrafish facility and a feeding regime was started. After 3-4 months, once the fish are 
deemed big enough, they were crossed pairwise with a wild type fish. The F1 embryos 
were then screened for fluorescence and any embryos showing specific expression 
were once again transferred to the zebrafish facility to be grown up. If required, a 
number of lines were established from different founder fish. Once the F1 generation 
were sexually mature, they were crossed together to produce homozygotes, 
heterozygotes and non-transgenics. Embryos showing fluorescence were selected 
before transferring them back to the zebrafish facility. Once the F2 generation were 
sexually mature, they were outcrossed to wild type fish and homozygotes and 
heterozygotes were identified by the proportion of their offspring showing reporter gene 
expression: 100 % and 50 % respectively.  
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3 INVESTIGATION OF THE FUNCTION OF PhiC31 
INTEGRASE IN ZEBRAFISH 
3.1 Introduction 
3.1.1 Variation in position effects during random integration transgenesis 
Currently, the most popular method for the study of enhancers in zebrafish involves 
utilising Tol2 transposase to facilitate the integration of an enhancer-promoter-reporter 
constructs into the zebrafish genome. Throughout early development the tissue-specific 
expression pattern of the enhancer being tested may be established by monitoring 
fluorescence in the developing zebrafish embryo.  
A major disadvantage of this method is that integration of the construct into the genome 
by Tol2 transposase is random. Therefore, the transgene in each injected embryo will be 
incorporated into a different locus within the genome. The position of the transgene may 
influence expression patterns of the reporter gene in a number of ways; for example, if a 
transgene integrates close to a genomic enhancer, it could interact with the promoter of 
the construct, driving the reporter gene expression. An example is depicted in Figure 
3-1, where 4 different zebrafish transgenic lines resulting from injections of the same 
construct under the same conditions are presented. The embryos were injected with a 
construct containing a putative enhancer of the estrogen-related receptor ɣ (errɣ) gene. 
The keratin four minimal promoter was selected as it has been shown to interact with a 
number of different known enhancers (Gehrig et al. 2009). For more details on this 
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construct, refer to Chapter 5. Each of the four lines exhibit different expression patterns 
and variances in the expression intensity. This data supports the commonly held belief 
that due to the random nature of construct integration and thus differences in flanking 
DNA composition, inconsistency in the interference experienced by the enhancer-
promoter-reporter transgene results in differences in reporter gene expression patterns.  
 
Figure 3-1 Tol2 transgenesis can result in large variability in positional effects 
Images of F1 embryos resulting from different founder zebrafish injected with the same construct and Tol2 
RNA. Individual lines show variability in intensity and expression pattern thought to be caused by random 
integration into different genomic loci. Figure adapted from Yavor Hadzhiev. The gateway vector contains 
Tol2 arms to facilitate integration (blue rectangles), ERRɣ El18 – a putative enhancer sequence (yellow 
rectangle), keratin 4 minimal promoter sequence (pink rectangle) and reporter gene venus GFP (green 
rectangle). 
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If construct integration could be targeted to the same genomic locus, thus overcoming 
the issues with random integration it would make zebrafish an even more attractive 
model for the study of cis-regulatory DNA.  
PhiC31 integrase is a protein already utilised to develop transgenic DrosoPhila lines and 
has been very successful. PhiC31 integrase facilitates the recombination between two 
recognition sites: attP and attB for more detailed information refer to section 1.4.3. 
3.1.2 Aims 
Current methods of studying enhancers in vivo using the zebrafish model involve 
transgenesis protocols that result in random genome integration. This is widely thought 
to lead to positional effects specific to the genomic context of the transgene, which can 
make it difficult to draw conclusions about expression patterns driven by specific 
enhancers. In order to overcome the inconsistencies associated with random 
integration, the aim of this work is to design a method to target integration of constructs 
to a specific locus within the zebrafish genome.  
Firstly, we need to establish whether PhiC31 integrase RNA can be translated by the 
zebrafish machinery when injected into the early embryo. Micro-injection of RNA is the 
most common method of providing early embryos with functional protein. The next 
objective is to find out if PhiC31 integrase can facilitate integration between a single attP 
site and a single attB site in the zebrafish model. We also aim to facilitate targeted 
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integration of a transgene into a specific locus of the zebrafish genome which is 
expected to reduce variability in position effects when injecting enhancer constructs. 
This integration should be detectable in vivo using live imaging of the zebrafish embryos 
without the need for laborious insertion site analysis. Therefore, we aim to identify 
embryos with targeted integration by utilising fluorescent reporter genes which mark 
targeted integration events. We aim to investigate the efficiency of PhiC31 integrase-
mediated genome integration and establish a transgenesis system suitable for use in 
many applications in the zebrafish model; such as enhancer testing or cell labelling. 
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3.2 Results 
3.2.1 Expression of PhiC31 in the zebrafish model 
To determine whether it would be possible to utilise PhiC31 integrase in the zebrafish 
model, the translation of in vitro synthesised mRNA and function of the protein was 
assessed. Firstly, mRNA coding for PhiC31 was produced by cloning the mouse codon 
optimised PhiC31 coding sequence (Raymond & Soriano 2007) into the pCS2+ vector. 
This was then linearised and PhiC31 RNA was transcribed in vitro and was injected into 
early stage zebrafish embryos. Next the embryos were grown in E3 medium at 28.5°C 
until they reached high stage. When the embryos reached high stage (approximately 
3.5hpf and over 1000 cells) the yolk was removed and the protein extracted from the 
cells. Western blot analysis (Figure 3-2) showed a band corresponding to PhiC31 
integrase in RNA-injected samples that was not present in protein extracted from non-
injected embryos. Non-specific bands are visible in both RNA-injected and non-injected 
samples. The non-specific bands appear stronger in the non-injected sample suggesting 
that the absence of the 67 kDa band cannot be due to less protein being loaded onto the 
SDS gel. This result suggests that PhiC31 integrase protein is produced by high stage 
from mRNA injected into a 1 cell stage zebrafish embryo. 
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Figure 3-2 PhiC31 integrase RNA is translated when injected into early stage zebrafish embryos 
The early stage embryos were injected with 20ng/µl PhiC31 RNA and 0.1% phenol red. At high stage 
(approximately 3.5hpf) the protein was extracted from a pool of 20 embryos for both the injected and non-
injected embryos. The western blot shows PhiC31 integrase protein (67 kDa) is present in injected 
embryos but absent in non-injected embryos. Primary antibody: Anti-Bacteriophage PhiC31 Integrase 
antibody and secondary antibody: anti-rabbit IgG. Non-specific binding of antibody to a protein is used as 
a loading control. 
3.2.2 Design and construction of vectors for investigating PhiC31 integrase 
function in zebrafish 
To test whether PhiC31 integrase can facilitate integration between the two recognition 
sites attP and attB, two constructs were designed: a recipient vector which contains a 
docking site for integration and an integration donor vector.  
Recipient construct 
The recipient construct was received from a collaborator, Darius Balciunas, Temple 
University, USA. It contains a 390 bp promoter sequence for the lens-specific ɣ-crystallin 
gene; this promoter was used to restrict expression of the reporter gene contained within 
the vector to the lens (Figure 3-3). The lens was selected as the marker as it is a 
relatively small tissue that doesn‟t obscure any other anatomy that may be labelled by 
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the reporter linked to the enhancer-promoter sequences. Downstream of the lens-
specific promoter is an 83 bp PhiC31 integrase recognition site attP and a GFP coding 
sequence with a polyA tail to stabilise the RNA being transcribed (Figure 3-3). The attP 
site was positioned between the promoter and reporter gene sequence to allow the 
targeted integration of the donor vector to be identified visually in vivo by the disruption 
of GFP expression (Figure 3-6). The ɣcry-attP-GFP sequence is flanked by Tol2 arms to 
facilitate the integration of the transgene to make transgenic recipient lines (Figure 3-3). 
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Figure 3-3 Schematic of the recipient vector 
The recipient vector contains Tol2 arms, ~390 bp of ɣ-crystallin promoter, 83 bp attP integrase recognition 
site, GFP coding sequence and a SV40 pA tail. Vector received from collaborator Darius Balcuinas at 
Temple University, USA.  
To test the tissue-specificity of the ɣ-crystallin promoter of the recipient vector, wild type 
embryos were co-injected with the recipient vector and Tol2 mRNA. The embryos were 
injected at 1-cell stage and incubated at 28.5 °C in E3 medium supplemented with 
gentamycin. They were then screened at 3-4 dpf for transient GFP expression (Figure 
3-4). Of 136 embryos co-injected with recipient vector and Tol2 RNA, 98 showed GFP 
expression specific to the lens (72.1 %). The rest of the embryos showed no GFP 
expression at all. This result suggests that the ɣ-crystallin promoter gives lens-specific 
GFP expression which is supported by subsequent results in this chapter (Figure 3-11). 
This shows that the ɣ-crystallin promoter is suitable for use in the recipient vector. 
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Figure 3-4 The recipient vector gives lens-specific GFP expression 
(A) Images of a 4 dpf stage embryo injected with 50ng/µl recipient vector DNA, 20ng/µl Tol2 RNA and 
0.1% phenol red. (B) Images of a 4 dpf control non-injected embryo. All images are a lateral view and 
anterior to the left. 
Donor construct 
The construct to be integrated (donor construct) will contain an attB site and a different 
fluorescent reporter protein (mCherry). This will enable us to identify embryos in which 
targeted integration has occurred as mCherry expression in the lens replaces GFP 
(Figure 3-6). There was no previous work published in zebrafish to evaluate the 
efficiency of PhiC31 integrase therefore we assumed that the number of embryos 
showing targeted integration of the two constructs may be limited and a screening step 
using fluorescent reporters may be required to detect the correct integration-containing 
embryos. 
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The donor vector was constructed by joining the attB sequence (from the fly vector 
pUASTattB (Bischof et al. 2007)) to the mCherry coding sequence with polyA tail by 
PCR of the two components. The reverse primer for the attB sequence contained a 
linker sequence that was complimentary to a linker sequence in the forward primer used 
to amplify the mCherry-pA sequence (Figure 3-5A). These two PCR products were 
combined and with the use of the attB forward primer and pA reverse primer another 
PCR was carried out to combine the two components due to the complementarity of the 
linker incorporated into the first sets of primers (Figure 3-5A). This PCR product was 
then cloned into pJET2.1 using the Clontech blunt-ended cloning kit. The resulting 
vector is depicted in Figure 3-5B. 
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Figure 3-5 Schematic of donor vector and its construction 
(A) A schematic of how the vector was constructed. Black arrows show PCR primers and the orange lines 
represent linker sequences included in the primers (B) A vector map of the donor construct (backbone is 
pJET1.2). 
In order to assess whether PhiC31 integrase can facilitate integration between the 
recipient and donor vectors, the experiment depicted in Figure 3-6 was designed. The 
co-injection of the recipient and donor vectors with PhiC31 integrase mRNA into wild 
type embryos was expected to result in integration between the vectors in an unknown 
proportion of the embryos. 
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Figure 3-6 Experiment design to test PhiC31 integrase function in zebrafish 
Co-injection of the recipient vector, donor vector and PhiC31 Integrase RNA is expected to result in the 
recombination of the two vectors, facilitated by PhiC31 integrase. 
3.2.3 Targeted integration of the donor vector into the recipient vector facilitated 
by PhiC31 integrase 
Next I needed to test whether PhiC31 integrase can facilitate integration between attP 
and attB sites in zebrafish. To do this, the recipient vector, donor vector and PhiC31 
Integrase RNA were co-injected into early stage wild type zebrafish embryos with the 
expectation that PhiC31 integrase would facilitate the integration of the two vectors 
(Figure 3-6).  
The embryos were grown as described previously and screened at 4 dpf for GFP and 
mCherry expression in the lens. Over 300 embryos were screened and none of them 
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showed mCherry expression in the lens which was expected to mark targeted 
integration. 
3.2.3.1 Evidence for targeted integration events by plasmid sequence analysis 
A lack of mCherry reporter activity could be due to a number of reasons: the efficiency of 
PhiC31 integrase could be too low for the mCherry to be detected visually, PhiC31 
integrase may not facilitate integration in zebrafish or there could be a problem with the 
transcription or translation of mCherry. To check if integration does occur but the 
reporter expression is insufficient to detect, I have chosen to study the sequence of the 
integration site by PCR and sequencing. Firstly, total DNA was extracted from three 
pools of 10 embryos co-injected with recipient vector, donor vector and PhiC31 
integrase mRNA and three pools of 10 embryos injected with recipient and donor vector 
only. A PCR was performed using a forward primer specific to the ɣ-crystallin promoter 
and a reverse primer specific to the mCherry coding sequence. If integration occurs then 
a 416 bp PCR fragment should be produced (Figure 3-6). When the recipient and donor 
vectors were injected with PhiC31 integrase mRNA, a band at approximately 416 bp 
was visible on an agarose gel (Figure 3-7A). The band was not present when the 
recipient and donor vectors were injected without PhiC31 integrase mRNA. This 
suggests that the targeted integration does not occur randomly, it only occurs in the 
presence of PhiC31 integrase. This was confirmed by a second PCR using a ɣ-crystallin 
forward primer and GFP reverse primer. A 1.1 kb (kilo base pairs) PCR product was 
expected to be produced in both samples as it would detect the presence of the non-
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integrated recipient vector. This confirmed that PCR-quality DNA was present in the 
control sample. The 416 bp PCR product was sequenced (carried out by Beckman 
Coulter Genomics) and a comparison to the known attR sequence (Bateman et al. 2006) 
confirmed that the recombination was legitimate (Figure 3-7B-C). Together, these data 
show that PhiC31 integrase can facilitate integration between attP and attB sites in 
zebrafish. However, these experiments do not provide information about the frequency 
of targeted integration in embryos. 
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Figure 3-7 Legitimate recombination occurs between the recipient and donor vectors  
(A) Image of an agarose gel showing the results of a series of PCRs using two pairs of primers on DNA 
extracted from embryos injected with recipient vector, donor vector and PhiC31 integrase mRNA or 
embryos injected with recipient and donor vectors without PhiC31 integrase mRNA. (B) Sequencing data 
from the 416 bp PCR product aligned to the expected sequence after recombination (according to 
published data (Bateman et al. 2006)). The red rectangle highlights the 3 bases at which the 
recombination occurs. The red and blue lines show sequence aligning to attP and attB (respectively) 
shown in (C). (C) Adapted from (Bateman et al. 2006) showing the partial sequences of attP, attB and 
attR. 
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3.2.4 Targeted integration of a donor construct to a predetermined genomic 
locus in zebrafish 
My next aim was to test if PhiC31 integrase can also target integration of a donor vector 
into a predetermined genomic locus. In order to target integration in the zebrafish, a 
PhiC31 target site first has to be introduced into the genome. This will be carried out 
using Tol2 transgenesis to introduce the recipient sequence into the genome of wild type 
embryos. Due to the mosaic nature of founders, the recipient sequence could integrate 
into the genome of gamete cells but not lens cells. This meant that all embryos 
(approximately 100) co-injected with the recipient vector and Tol2 RNA were taken to 
the zebrafish facility to be grown to sexual maturity.  
Founder recipient line fish were identified by outcrossing the adult fish to wild type fish. 
The F1 embryos were screened at 4 dpf and the fish which gave rise to a clutch 
containing embryos with GFP expression in the lens were separated. Of 36 adult fish 
screened, 6 transgenic recipient line founders were identified (16.7 %); none of these 
showed any ectopic expression which would indicate positional effects and GFP 
expression was specific to the lens. The germline transmission rates varied from 5-60% 
between the 6 lines (Table 5-1). The F1 embryos showing lens GFP expression were 
grown up and 6 stable transgenic lines were established. Once the F1 generation 
reached sexual maturity they were outcrossed again to wild type fish and the embryos 
screened for GFP expression. Mendelian genetics appeared to be observed suggesting 
that the transgene had integrated in a single genomic locus. The GFP expressing 
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heterozygous F2 generation were grown to adulthood and the F2 adults were used in 
further experiments. 
To establish whether PhiC31 integrase can facilitate integration of a donor vector into the 
target site of a recipient line embryo, the following experiment was designed. An adult 
recipient line fish will be crossed with a wild type fish and the fertilised eggs will be 
injected with donor vector plus PhiC31 integrase mRNA or donor vector alone as a 
control. The schematic in Figure 3-8 shows the outline of the experiment and the 
expected outcome. When co-injected with PhiC31 integrase mRNA, the donor vector is 
expected to recombine with the attP target site in the recipient line and the whole vector 
be integrated into that locus. This is expected to result in the expression of mCherry in 
the lens replacing GFP. When the donor vector is injected alone into the recipient line 
embryos, it is expected that the recombination event will not occur and therefore the 
embryos will show GFP expression in the lens not mCherry. As a heterozygous recipient 
line fish will be used, approximately 50% of the offspring is expected to carry the target 
site for integration. 
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Figure 3-8 Schematic of the experiment to test the function of PhiC31 integrase to target 
integration into a transgenic zebrafish genome 
(A) An adult recipient line fish will be crossed with a wild type fish. (B) The embryos will be co-injected with 
100ng/µl donor vector, 20ng/µl PhiC31 RNA and 0.1% phenol red. (C) The expected result is that the 
donor vector integrates into the target site and the ɣ-crystallin promoter now drives expression of mCherry, 
not GFP.  
In order to screen for targeted genomic integration by switching of reporter gene activity, 
the embryos were screened at 4 dpf for GFP and mCherry expression in the lens. Over 
500 embryos were screened and none of these showed mCherry expression in the lens. 
However, as expected approximately 50% of embryos expressed GFP in the lens 
74 
 
indicating those embryos that contained the target site. This result suggests that either 
the donor vector does not integrate into the target site or that mCherry expression is too 
low to detect/ absent despite the occurrence of targeted integration. 
To check whether targeted genomic integration does occur and reporter gene activity is 
too low to detect, the PCR test for integration was carried out on total DNA extracted 
from the recipient line embryos injected with donor construct and PhiC31 integrase 
mRNA and showed the 416 bp band was visible (Figure 3-9A). The PCR product was 
isolated and purified and then digested with a restriction enzyme which cuts between the 
ɣ-crystallin promoter and the attP/R (BamHI) to ensure the PCR product resulted from a 
legitimate integration. As a control, PCR product that had been sequenced in the 
previous experiment (Figure 3-7) was also digested with BamHI. These test digests 
confirmed that the PCR product was specific and the integration had occurred 
legitimately at the attP site (Figure 3-9B). This data shows that PhiC31 integrase can 
facilitate the integration of a donor vector into a predetermined site in the zebrafish 
genome. The lack of reporter gene activity switching means that the frequency of 
targeted integration in the embryos is still unknown. 
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Figure 3-9 The donor vector is legitimately targeted to integration site in recipient line 1 
(A) Gel image shows the junction fragment detected by PCR product using a ɣ-crystallin forward primer 
and a mCherry reverse primer indicating that PhiC31 integrase has facilitated the correct integration of the 
donor vector. (B) Gel picture showing PCR products digested with BamHI to show the recombination 
occurred at the attP site downstream of the ɣ-crystallin promoter. Lane a - DNA was harvested from 
embryos injected with donor vector and PhiC31 integrase RNA, a PCR was carried out to amplify the 
integration site and the product was digested between the ɣ-crystallin promoter and the attP site with 
BamHI. Lane C shows sequenced PCR product from Figure 3-7 digested with BamHI as a positive 
control. Lanes B and D show undigested PCR products for comparison. 
3.2.5 Optimisation of the visual readout for targeted integration 
Targeted integration appeared to be fairly efficient because at least 1 in 10 embryos had 
targeted integration indicated by the results from PCR on pools of 10 embryos, however 
no mCherry was detected. A hypothesis was made that translation of mCherry could be 
affected by the attR sequence between the ɣ-crystallin promoter and the start codon. 
Therefore, the sequence of attB was checked for alternative start codons that could be 
influencing translation of mCherry. The 285 bp attB sequence from pUASTattB contains 
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4 ATG codons in the correct orientation (Figure 3-10). Of these four ATGs, three would 
also be present in the attR sequence after integration. None of these start codons were 
in frame with mCherry and so all of them could potentially cause a frameshift which 
could explain the lack of mCherry expression despite evidence of targeted integration. It 
has previously been published that shorter attP and attB sequences also function and so 
an 84 bp attB sequence was checked for any ATGs (Figure 3-10). There were no 
alternative ATGs predicted and so this sequence was used to build a new donor vector 
in the same manner as described in Figure 3-5. 
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Figure 3-10 Full length attB contains start codons causing a frame shift in mCherry 
(A) Schematic showing the full length attB from pUASTattB used to make transgenic DrosoPhila. The 
green rectangle represents the attB sequence, the yellow lines mark the locations of the ATG codons that 
are in the correct orientation and the red stars represent the ATGs that would be present in the attR 
sequence after integration. (B) Schematic showing the 84bp attB, attachment sites of this length have 
been shown to function previously (Thorpe & Smith 1998).   
3.2.6 Analysis of the efficiency of PhiC31 integrase-mediated integration into the 
zebrafish genome 
My next aim was to test whether targeted integration of a new donor vector containing a 
shorter attB site would result in the expression of mCherry in the lens. This new donor 
vector was tested by co-injection with the recipient vector and PhiC31 integrase into wild 
type embryos. When these embryos were screened at 4 dpf, 59.3% showed mCherry 
expression in one or both lenses (Figure 3-11A-B). The percentage of fluorescing 
embryos showing mCherry expression in the lens was over 98% (Figure 3-11C). These 
results suggest that PhiC31 integrase facilitates efficient targeted integration of a donor 
vector into a recipient vector in zebrafish. Throughout the rest of this thesis, donor vector 
refers to this vector with a shorter attB sequence. 
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Figure 3-11 The recombination event between co-injected vectors is highly efficient 
(A) Panel A shows an image of a 4 dpf embryo expressing mCherry in the lens. (B) The bar chart shows 
the percentage of total embryos screened showing mCherry and/or GFP expression in the lens after a 
number of control solutions were injected. (C) The bar chart displays the percentage of fluorescent 
embryos that were positive or negative for mCherry expression in the lens. Using the chi-squared test, 
these results were statistically significant (** p<0.001). 
To test whether the targeted integration of the new donor vector would result in mCherry 
expression in the lens, the donor vector was injected alone or co-injected with PhiC31 
integrase mRNA into recipient line 1 embryos. The embryos were screened at 4 dpf and 
the results show that more than 70% of the transgenic embryos injected with donor 
vector and PhiC31 integrase mRNA had mCherry expression in the lens (Figure 3-12A 
and B). None of the embryos injected with donor vector alone showed mCherry 
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expression in the lens (Figure 3-12A bottom panel). This supports the evidence that 
recombination between attP and attB cannot occur randomly in the absence of PhiC31 
integrase collected in transient transgenic embryos (Chapter 3.2.3). Another recipient 
line was also tested for targeted genomic integration. Recipient line 2 embryos were co-
injected with donor vector and PhiC31 integrase mRNA and showed very similar rates of 
targeted integration (around 70%) as recipient line 1 (Figure 3-12C). This provides 
evidence that PhiC31 integrase can facilitate efficient targeted integration of the donor 
vector into a predetermined site in the zebrafish genome. 
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Figure 3-12 Co-injection of donor vector and PhiC31 integrase RNA results in mCherry expression 
in the lens of over 70% of transgenic embryos 
(A) The top panel shows a recipient line 1 embryo which was injected with the donor vector and PhiC31 
integrase RNA. The bottom panel shows a recipient line 1 embryo injected with donor vector only. Images 
are lateral view and anterior to the left.(B) The bar chart shows the percentage of transgenic recipient line 
1 embryos that are mCherry positive in the lens when donor vector is injected alone vs co-injected with 
PhiC31 integrase RNA. (C) A bar chart showing the percentage of transgenic recipient line 1 and 2 
embryos injected with the donor vector and PhiC31 integrase RNA that had mCherry expression in the 
lens. Recipient lines 1 and 2 are lines made from two different founders ie the integration sites are in a 
different locus in each line. 
When screening the injected recipient line embryos for mCherry and GFP expression in 
the lens, both eyes of the embryo had to be screened as the integration of the donor 
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vector was mosaic. The majority of mCherry positive embryos only expressed mCherry 
in one lens (Figure 3-13). This mosaicism also explains why embryos co-expressing 
mCherry and GFP in the same lens were observed. 
 
Figure 3-13 Mosaic integration of the donor construct into the recipient line 1 genome 
The bar chart shows the proportion of 228 recipient line 1 embryos that show mCherry expression in one, 
both or neither lens. 
3.2.7 Survival of zebrafish injected with PhiC31 integrase mRNA 
A high proportion of embryos injected with PhiC31 integrase mRNA were abnormal or 
did not survive to 24 hpf. To test whether the low survival of mRNA-injected embryos was 
specific to PhiC31 integrase mRNA, the survival of embryos injected with Tol2 mRNA 
was used as a comparison. The low survival rate of PhiC31 integrase mRNA-injected 
embryos was observed consistently throughout the experiments described in this 
Chapter; on average less than 35% of PhiC31 integrase RNA-injected embryos would 
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survive to 24 hpf (Figure 3-14). Survival of PhiC31 integrase mRNA-injected embryos 
was significantly reduced (p=0.0054) when compared with embryos injected with Tol2 
mRNA. This result suggests that PhiC31 integrase mRNA is causing a high proportion of 
embryos to develop abnormally and die early in development.  
 
Figure 3-14 Survival of PhiC31 integrase RNA-injected embryos is significantly reduced 
The bar chart shows the percentages of PhiC31 integrase and Tol2 mRNA-injected embryos to survive to 
24 hpf. Using a binomial model, the p value= 0.00554 (** represents p<0.01). 
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3.3 Discussion 
3.3.1 Translation of Phi31 integrase RNA by the zebrafish embryo 
At the start of this project, there was no data published on using PhiC31 integrase in 
zebrafish and so firstly, the delivery of PhiC31 integrase protein had to be confirmed. 
The standard delivery in other transgenesis methods (eg Tol2 and SB) is injection of 
mRNA coding for the transposase (Kawakami et al. 1998). Therefore, I needed to 
establish whether PhiC31 integrase mRNA could be translated using the zebrafish 
translation machinery. I found that PhiC31 integrase protein was translated by the 
zebrafish embryo after micro-injection of mRNA. PhiC31 integrase mRNA was injected 
into early stage wild type zebrafish embryos and at 3.5 hpf, protein was extracted from 
the embryos and a western blot was performed. A band corresponding to PhiC31 
integrase was detected in the PhiC31 integrase mRNA-injected sample but not the non-
injected control. This data suggests that PhiC31 integrase expression is induced in the 
zebrafish by injection of mRNA. However, the western blot does not give us information 
about efficiency of translation or biochemical activity of the protein. 
3.3.2 PhiC31 integrase transgenesis system 
The development of a targeted integration system in zebrafish would have a wide range 
of uses. These had to be considered while designing the PhiC31 integrase system and 
the constructs involved so that it would be suitable in a wide range of applications.  
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With the input of our collaborator, Darius Balciunas, we designed an integration system 
which involves the integration of the whole of the donor construct. This allows the use of 
a single attP site in the recipient construct or line and a single attB site in the donor 
vector. Although integration using single recognition sites had never been tested, it had 
previously been published that PhiC31 integrase can induce excision of a DNA 
sequence flanked by an attP and attB site in mouse (Sangiorgi et al. 2008) proving that 
recombination reactions can occur between single attP and attB sites in a vertebrate 
model. This has now also been shown to occur in zebrafish (Figure 1-7). The use of 
single recognition sites may improve the efficiency of targeted integration by PhiC31 
integrase compared with recombination-mediated cassette exchange (RMCE) utilised in 
DrosoPhila (Bateman et al. 2006) and more recently in zebrafish (Hu et al. 2011). In 
RMCE, two recombination reactions have to occur in order to integrate the donor 
sequence flanked by attB sites (Figure 1-8). This double recombination reaction may 
reduce the efficiency of PhiC31 integrase-mediated integration (Hu et al. 2011).  
The integration of the whole construct is expected to allow the targeted integration of 
larger DNA sequences which may be restricted when using RMCE. This again widens 
the number of techniques that could be employed using the PhiC31 integrase system; for 
example, BAC transgenesis. We do, however, need to be aware that the integration of 
the whole construct leads to the integration of bacterial DNA sequences (in the vector 
backbone) that could influence transgene activity. Currently, there is no evidence to 
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suggest that the vector backbone does have a detrimental effect on the PhiC31 
integrase system or activity of inserted reporter constructs. 
We positioned the promoter upstream of the attP integration site in the recipient 
construct despite the possibility that this could lead to problems during transcription and 
translation of the fluorescent reporter genes. This was to ensure that the fluorescent 
reporter colour change would specifically identify those embryos in which targeted 
integration has occurred. This design meant that the donor vector did not have to 
contain any regulatory DNA at all (ie. a promoter). If the donor vector contained a 
promoter sequence upstream of the mCherry sequence, expression of mCherry could 
be driven if the vector integrated randomly in the genome non-related to Phi31 integrase 
(Figure 1-8). 
The use of mouse codon optimised Phi31 integrase (Sangiorgi et al. 2008) has been 
shown to work significantly more efficiently in zebrafish than the phage PhiC31 integrase 
(Lister 2010). This supports our decision to use the mouse codon optimised PhiC31 
integrase sequence to make the RNA for injections. 
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3.3.3 PhiC31 integrase-mediated integration between attP and attB in zebrafish 
Once the system had been designed and the constructs made, I needed to ascertain 
whether PhiC31 integrase can function in zebrafish to integrate two constructs, each 
containing a recognition site (attP in the recipient and attB in the donor). I have provided 
data that shows that PhiC31 integrase not only can facilitate the integration between 
these two constructs but that it does so with an efficiency of approximately 98% (Figure 
3-11). This demonstrates that PhiC31 integrase can facilitate whole vector integration 
between single attP and attB sites. This was a good start but is not particularly useful as 
this is in transient transgenics but we want to target integration into the genome. This 
experiment was carried out to show the system has potential and meant that I needed to 
make the recipient lines to target genomic integration. 
3.3.4 Targeted integration into the genome of a transgenic zebrafish 
In order to study cis-regulatory elements in zebrafish, transgenesis methods are 
employed to integrate a transgene into the genome. In order to use PhiC31 integrase as 
a transgenesis system, a recipient transgenic line needs to be made with a target 
integration site, attP. Using a recipient line containing a target site, I showed that PhiC31 
integrase can facilitate the integration of a whole donor construct into the site (Figure 
3-9). This targeted integration occurs in over 70% of embryos screened at 3-4 dpf 
(Figure 3-12). Targeted integration into the zebrafish genome by RMCE using PhiC31 
integrase has been published previously (Hu et al. 2011); however, it has never been 
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shown that PhiC31 integrase can facilitate integration between single integration sites 
rather than RMCE. The efficiency of targeted integration in F0 embryos using RMCE has 
not been specified in previous publications and so we still don‟t know if the efficiency is 
improved by the use of single recognition sites. 
3.3.5 Visualisation of targeted integration in vivo 
The identification of embryos with targeted integration is essential whilst the embryo is 
alive in order to be able to study the effects as the embryo develops. This means that 
DNA extraction and PCR are not suitable for screening targeted integration. A 
fluorescent reporter system is the ideal way to identify those embryos in which 
integration of the construct has been targeted to the correct locus. After initial issues 
with the translation of mCherry after targeted integration were solved (Figure 3-10), our 
system provided a clear marker for embryos in which targeted integration had occurred. 
We selected a lens-specific promoter as our collaborators have previously studied the 
promoter (Davidson et al. 2003) and the lens is a small tissue that doesn‟t interfere with 
potential tissues of interest. In recent publications of the use of PhiC31 integrase in 
zebrafish, regulatory DNA for the sox10 (Hu et al. 2011) and ef1α (Lister 2010) genes 
have been used to drive fluorescent reporter expression. The expression of the reporter 
gene is therefore throughout the whole embryo meaning it is not suitable for studying 
novel enhancers using another fluorescent reporter gene.  
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3.3.6 Mosaicism of targeted genome integration 
A common issue with injection of zebrafish embryos, including when studying 
fluorescent reporter expression patterns driven by novel enhancers, is mosaicism of the 
injected embryos (Fisher et al. 2006). The mosaic pattern may mean that very few cells 
express the fluorescent protein and therefore either cannot be detected or the tissue 
cannot be identified. As I have shown in Figure 3-13, targeted genomic integration in 
zebrafish by PhiC31 integrase is mosaic. This is supported by the observations that GFP 
expression is not lost even when the lens also shows mCherry expression and that the 
majority of embryos showing mCherry expression only had it in one eye. Therefore the 
integration must have occurred after the progenitor lens cells had been split into left and 
right. This mosaicism also occurs when using RMCE in zebrafish shown by the co-
expression of both GFP and dsRed reporters (Hu et al. 2011).  
To combat this problem, stable transgenic lines often have to be made using Tol2 
transposase which is both time consuming (4 months to grow the fish) and costly (to 
maintain large numbers of founder fish in the facility). To reduce mosaicism in injected 
embryos would enable us to better screen F0 fish saving a lot of time and money 
compared to making stable lines for each enhancer construct. Reducing mosaicism 
would also increase the chances of germline transmission of the transgene, improving 
the efficiency of making stable transgenic zebrafish lines. 
89 
 
3.3.7 Toxicity of PhiC31 integrase 
The data in Figure 3-14 clearly shows that survival of PhiC31 integrase mRNA-injected 
embryos is significantly reduced compared with Tol2 mRNA-injected embryos. This has 
also been observed by others using PhiC31 integrase in zebrafish (Hu et al. 2011). They 
found that when PhiC31 integrase mRNA was injected at more than 20 pg per embryo 
they observed developmental abnormalities and when it was injected at 40 pg per 
embryo the frequency of embryos showing abnormalities was high. They chose to 
reduce the dosage to 20 pg and have normally developed embryos. I decided to inject at 
higher concentrations of PhiC31 integrase mRNA, 20 ng/µl (approximately equivalent to 
40 pg per embryo), because I found that the efficiency of PhiC31 integrase dropped 
when using lower PhiC31 integrase mRNA concentrations. A higher concentration of 
PhiC31 integrase mRNA, although reduces survival, allows a higher rate of integration 
and has the advantage of less embryos to screen and less adult fish required to find a 
founder. This means that fewer lines have to be grown up, saving space and cost 
maintaining the fish. 
The cause of the toxicity of PhiC31 integrase RNA is unknown. Double-stranded RNA 
(dsRNA) injected at high concentrations is known to cause general developmental 
defects in zebrafish embryos (Zhao et al. 2001). However, the toxicity is specific to 
PhiC31 integrase as when Tol2 transposase RNA is injected at the same concentration, 
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survival is significantly higher and so dsRNA cannot be causing the developmental 
abnormalities. 
It has previously been found that chromosomal translocations occur in human fibroblasts 
in the presence of PhiC31 integrase (Liu et al. 2009). One logical explanation for the 
toxicity in zebrafish is that PhiC31 integrase causes recombination effects between 
pseudo attP sites in the zebrafish genome, causing lethal translocations of 
chromosomes. However, using a BLASTn search of the zebrafish genome on NCBI 
(Altschul et al. 1990) for the 84 bp attP sequence gives 3 „somewhat similar‟ genomic 
sequences. None of these contain both the essential TTG and surrounding region 
required for PhiC31 integrase-facilitated recombination. This suggests that there are no 
pseudo attP sites in the zebrafish genome that could result in chromosome 
translocations in the presence of PhiC31 integrase. The cause of the toxicity specific to 
PhiC31 integrase mRNA still remains unknown. 
3.3.8 Conclusions 
PhiC31 integrase can facilitate targeted integration into the genome of a transgenic 
zebrafish embryo. I have designed (along with collaborators) and verified an efficient 
targeted genomic integration system in zebrafish, utilising fluorescent reporter genes to 
identify embryos in which targeted integration has occurred. This system will provide 
another tool for the zebrafish research community to study cis-regulatory DNA. This 
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system could also be used for any experiment requiring integration into a consistent 
genomic context.  
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4 COMPARING THE EFFICIENCY OF PhiC31 INTEGRASE-
MEDIATED GENOME INTEGRATION USING DIFFERENT 
DELIVERY METHODS OF PhiC31 INTEGRASE: RNA VS 
MATERNAL PROTEIN 
4.1 Introduction 
Mosaicism of transient transgenic embryos often causes problems when studying 
integrated enhancer-promoter-reporter sequences (Fisher et al. 2006). This mosaicism 
is caused by a delay in integration of the transgene due to the production of functional 
protein by translation of the mRNA. This means that the PhiC31 integrase protein may 
only be present in a subset of the embryo‟s cells which results in a mosaic F0 fish 
(Figure 3-13). Providing functional protein earlier may reduce mosaicism and reveal 
enhancer pattern in founder fish. This could be a much quicker method of studying 
enhancers rather than growing fish to adulthood for 4 months to screen the non-mosaic 
F1 generation embryos. A reduction in mosaicism would also increase the efficiency of 
germline transmission when making stable transgenic zebrafish lines. 
An oocyte-specific cre transgenic zebrafish line was previously made to provide Cre in 
the early embryo (Liu et al. 2008). This was made using the zebrafish zona pellucida 3 
(zp3) promoter previously characterised by the same group (Liu et al. 2006). Zona 
pellucida is a glycoprotein expressed specifically in the oocytes of female vertebrates 
(Liu et al. 2006). In this paper, they make a zp3:gfp transgenic line and show GFP 
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expression in zebrafish oocytes and early embryos until it gradually disappears by 3 dpf. 
The presence of GFP at the one-cell stage suggests that a zp3:PhiC31 line will provide 
a functional protein at the time of micro-injection of a DNA construct. As a result, 
integration is expected to occur earlier and therefore mosaicism would be reduced and 
enhancer tissue-specificity patterns could be revealed in injected embryos. 
Providing maternal PhiC31 integrase protein rather than RNA may also improve the 
survival of embryos. 
4.1.1 Aims 
To develop a transgenic line to provide PhiC31 integrase protein in the early zebrafish 
embryo with the expectation that it will allow earlier integration of the donor vector and 
therefore result in less mosaic F0 embryos. I then plan to test the function of this 
maternal PhiC31 integrase transgenic line by crossing the fish with a recipient line fish 
and injecting the embryos with the donor construct. 
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4.2 Results 
4.2.1 Design and construction of a vector to make a maternal PhiC31 integrase 
transgenic line in zebrafish 
With the aim of integrating an enhancer-promoter-reporter construct at an earlier 
developmental stage, a maternal PhiC31 integrase line female will be crossed with a 
recipient line male and the embryos injected with the donor construct (Figure 4-1). Due 
to the presence of functional PhiC31 integrase protein at the time of injection of the DNA 
construct is expected to result in earlier integration of the donor construct which is 
expected to manifest in both lenses showing mCherry expression and increase 
efficiency of transmission of the transgene to the next generation through the germline. 
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Figure 4-1 Schematic showing the use of a maternal PhiC31 line to target genomic integration 
(A) represents a maternal PhiC31 integrase line female fish being crossed to a male recipient line fish. (B) 
Embryos will then be injected with the donor construct alone. (C) The mCherry positive embryos are 
expected to show a less mosaic pattern ie. they would show mCherry expression in both lenses not just 
one. 
In order to create a maternal PhiC31 integrase transgenic line, a construct was made 
containing two zp3 promoter sequences driving expression of both PhiC31 integrase 
and blue fluorescent protein (BFP) (Figure 4-2). BFP was included as a screening 
marker for identification of transgenic embryos, allowing them to be selected for 
analysis.  
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Figure 4-2 Schematic of the cloning steps to make a maternal PhiC31 integrase line 
Firstly, PhiC31 integrase was cloned into a vector containing the zp3 promoter sequence (Pzp3) (A). 
Simultaneously, BFP was cloned into the same vector (B).The Pzp3-BFP fragment was then cloned 
into pT2KXIGin which contains Tol2 arms for DNA integration (C). Lastly the Pzp3-PhiC31 sequence 
was cloned upstream of the Pzp3-BFP to make pT2-INT-BFP (D).    
4.2.2 Generation and identification of maternal PhiC31 integrase founder 
fish 
To generate a stable maternal PhiC31 integrase line, the construct shown in Figure 4-2 
was co-injected with Tol2 mRNA and approximately 60 embryos were grown to adult 
fish. For this transgenic line the injected fish cannot be screened, only the F1 
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generation. Once injected fish were 4-5 months old the females were outcrossed and 
the embryos were dechorionated at 1-cell stage and screened on a fluorescence 
microscope as soon as possible (Figure 4-3). Once a founder female fish was identified 
by the detection of BFP in her offspring, all her eggs were grown up to generate a stable 
line. In the meantime, the founder females were used in subsequent experiments. 
 
Figure 4-3 Images of a maternal PhiC31 line showing BFP expression in the early embryo 
(A) shows images of an 8 cell stage F1 BFP positive embryo from the maternal Phi31 integrase line 1. (B) 
shows images of an 8-16 cell stage F1 BFP negative embryo from the founder of maternal PhiC31 
integrase line 1. (C) shows images of an 8 cell stage control non-injected wild type embryo. 
98 
 
4.2.3 Targeted integration function of the maternal PhiC31 integrase protein 
To assess whether providing PhiC31 integrase protein maternally could facilitate 
targeted integration into the target site of a recipient line embryo, two founder females 
were tested by crossing with recipient line males and injecting the embryos with the 
donor construct. The embryos were screened before epiboly began and the BFP 
positive embryos were separated from the BFP negative embryos in order to identify at 
later developmental stages which embryos had had maternal PhiC31 integrase. The 
embryos were incubated at 28.5 °C and the medium was changed every day. At 4 dpf 
the embryos were screened for mCherry and GFP expression in the lens.  
Maternal integrase line 1 offspring showed a reduced level of survival among the BFP 
positive embryos compared to their sibling BFP negative embryos (Figure 4-4A). When 
line 1 BFP positive embryos were screened for mCherry expression in the lens, over 
50% of embryos containing the target site showed targeted integration (Figure 4-4B). 
Unexpectedly, there were also around 11% of „BFP negative‟ embryos showing mCherry 
expression. All of my previous data suggests targeted integration does not occur without 
the presence of PhiC31 integrase. Therefore, I propose that these mCherry positive 
embryos are embryos that were BFP positive but were not selected during the early 
screening due to the difficulties encountered in detecting low levels of BFP fluorescence.  
Maternal PhiC31 integrase line 2 showed no reduction in survival of BFP positive 
embryos compared to their BFP negative siblings. When they were screened at 4 dpf for 
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mCherry expression in the lens, no positives were found to indicate targeted integration 
in either BFP positive or BFP negative embryos (Figure 4-4B). 
Together, these data support the data in Chapter 3 to suggest that the concentration of 
PhiC31 integrase in the early zebrafish embryos influences survival of those embryos. 
These data also provide evidence for the hypothesis that lower PhiC31 integrase 
concentrations, result in a reduced frequency of targeted integration. 
 
Figure 4-4 Efficiency of targeted integration by PhiC31 integrase is linked to survival of embryos 
(A) Bar chart showing the percentage of embryos from a cross between the maternal Phi31 integrase line 
and the recipient line injected with the donor construct to survive to 24 hpf. (*** p<0.001). (B) A bar chart 
displaying the percentage of embryos containing the attP target site that show mCherry expression in the 
lens. 
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4.2.4 The effects of PhiC31 integrase delivery method on mosaicism 
In order to assess whether the maternal PhiC31 integrase allowed early integration and 
reduced mosaicism, the percentage of mCherry positive embryos that showed 
expression in both lenses was analysed. The data analysed was from the experiment 
described in Chapter 3.2.6 when recipient line embryos were injected with donor vector 
and PhiC31 integrase mRNA and the proportion of embryos showing mCherry 
expression in one, both or neither lens was shown in Figure 3-13. The mosaicism of the 
embryos resulting from crosses of the recipient line fish and maternal PhiC31 integrase 
line fish (Chapter 4.2.3) were also assessed in the same manner, by recording whether 
mCherry was expressed in one, both or neither lens. When using maternal PhiC31 
integrase line 1, 44.4% of mCherry positive embryos showed expression in both lenses. 
This was compared to the percentage of mCherry positive embryos displaying mCherry 
expression in both lenses when using Phi31 integrase mRNA, which was 38.3%. 
Binomial tests were carried out to confirm that there is no significant difference between 
these data (p=1.0) which suggests that providing maternal PhiC31 integrase does not 
result in reduced mosaicism compared to providing PhiC31 integrase mRNA. 
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Figure 4-5 There is no evidence to suggest that the maternal PhiC31 integrase line reduces 
mosaicism 
The bar chart compares the percentage of mCherry positive embryos that had mCherry expression in both 
lenses when using the maternal PhiC31 integrase line or PhiC31 integrase RNA. Error bars show 1 
standard deviation from the mean of four different experiments carried out on different days.  
In order to generate stable maternal PhiC31 integrase lines, F1 adult fish were screened 
for transgenics. To more rapidly screen for transgenic F1 fish, fin clips were taken and 
the genomic DNA extracted. When this genomic DNA was tested by PCR for presence 
of the PhiC31 integrase coding sequence, no transgenic F1 fish were identified out of 48 
fish tested from 3 maternal PhiC31 integrase lines. This lack of transgenic F1 fish may 
be due to the reduced survival of embryos containing PhiC31 integrase. 
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4.3 Discussion 
The aim of this work was to reduce mosaicism in embryos injected with transgenes that 
were integrated into the genome. A reduction in mosaicism is expected to improve the 
study of putative enhancer sequences in vivo in enhancer-promoter-reporter construct-
injected embryos. It would also improve the efficiency of transmission of the transgene 
through the germline, which would be useful in many research labs who generate stable 
transgenic zebrafish. Previously published data show that a maternal cre line can 
facilitate excision of loxP flanked DNA sequences in the zebrafish embryo (Liu et al. 
2008). We hypothesised that PhiC31 integrase could do the same and that providing 
functional protein at the time of injection of the donor vector would mean earlier 
transgene integration and therefore, less mosaicism. 
4.3.1 Maternal PhiC31 integrase construct design 
The oocyte-specific zp3 promoter was selected as it has already been characterised in 
zebrafish and a zp3:gfp transgenic line showed that protein was present at the 1-cell 
stage. It has already been used to make a functional maternal cre transgenic zebrafish 
line (Liu et al. 2008) and this makes it ideal for making a maternal PhiC31 integrase line. 
The fluorescent reporter used to screen the maternal PhiC31 integrase line had to be 
designed carefully so as not to interfere with expression patterns of other fluorescent 
proteins utilised in the system. As described previously, protein expressed from the zp3 
promoter doesn‟t degrade until around 3 dpf (Liu et al. 2006). This immediately ruled out 
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both GFP and mCherry/RFP as screening tools for the maternal PhiC31 integrase line. 
We also plan to use cyan fluorescent protein (CFP) and yellow fluorescent protein (YFP) 
to label enhancer-promoter expression in future experiments. This left BFP as the only 
fluorescent protein that we could detect without interference and bleed through from 
other fluorescent protein signals detected by our fluorescent microscopes. BFP is not a 
commonly used fluorescent protein in zebrafish and so it was tested for activity prior to 
making this construct. The BFP coding sequence was cloned into the pCS2+ vector and 
mRNA was synthesised in vitro. This mRNA was then injected into wild type embryos 
and they were screened at 24 hpf for BFP fluorescence which was easily detectable in 
these embryos (data not shown). This showed that BFP could be used in zebrafish and 
we had the means to detect it in vivo. Despite this data, BFP did not prove to be an 
effective screening tool for this maternal transgenic line. The PhiC31 integrase lines 
were not very easily screened as the BFP was very weak and difficult to detect. This 
made the screening process lengthy and not 100% accurate (Figure 4-4). 
4.3.2 Targeted genomic integration using a PhiC31 maternal integrase 
Despite the issues with screening, the maternal PhiC31 integrase line can facilitate 
targeted genome integration into a recipient line (Figure 4-4). This shows that the zp3 
promoter is driving expression of the PhiC31 integrase as well as the BFP. However, the 
second line tested did not show any embryos with targeted integration; this could be due 
to variability in the concentration of PhiC31 integrase present caused by position effects 
as the transgene integrated randomly.  
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4.3.3 The effects of maternal PhiC31 integrase on mosaicism 
 By screening both lenses for the expression of mCherry, I provided a way of assessing 
the mosaicism of the injected embryos. In embryos expressing mCherry in only one 
lens, the integration must have occurred after the lens lineage cells split into right and 
left. However, embryos expressing mCherry in both lenses must have had an earlier 
integration resulting in a less mosaic pattern. Based on observation of integrations using 
both PhiC31 integrase RNA and the maternal PhiC31 integrase line, there is no evidence 
to suggest that a maternal PhiC31 integrase line reduces mosaicism in F0 embryos.  
4.3.4 Technical problems with the use of maternal Phi31 integrase lines 
The maternal PhiC31 integrase founder fish were unreliable at laying eggs which made it 
very difficult to obtain enough embryos to carry out the experiments. This led to lower 
numbers of embryos screened reducing the chances of getting statistically significant 
results. The cause of the lack of numbers of eggs laid is unknown; it could be related to 
the presence of toxic levels of PhiC31 integrase in the oocytes of the transgenic females. 
When founder females were identified by clutches containing BFP expressing embryos, 
the clutches were grown up to make a stable transgenic line. However, when the F1 fish 
were screened, no transgenic fish were found out of 48 screened from 3 different 
maternal lines. It is possible that the transgene was selected against as the PhiC31 
integrase positive ones seem to be less likely to survive. 
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Others have addressed the same issue by using PhiC31 integrase mRNA with an 
untranslated region (UTR) of the nanos1 gene which targets the mRNA to the germline 
precursor cells and therefore is expected to result in more efficient transmission of the 
transgene to the next generation (Hu et al. 2011). Injection of PhiC31 integrase-
nanosUTR mRNA is not reported to reduce survival of embryos that occurs with the 
PhiC31 integrase mRNA that I used. 
4.3.5 Conclusions 
From my experiments there is no evidence to suggest that providing PhiC31 integrase 
maternally reduces mosaicism and the survival of embryos does not appear to be 
improved. This suggests that using a maternal PhiC31 integrase line may not provide an 
advantage over injections carried out with PhiC31 integrase mRNA. Taking this into 
consideration and the problems encountered when trying to make a stable line, the 
maternal PhiC31 integrase line does not look to be a suitable alternative to PhiC31 
integrase RNA. The use of PhiC31 integrase-nanosUTR mRNA by other researchers 
may improve the efficiency of transgene transmission in the germline but this will not aid 
the study of enhancers in F0 embryos. 
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5 NOVEL ENHANCER FUNCTION IDENTIFIED BY USING THE 
PhiC31 INTEGRASE SYSTEM 
5.1 Introduction 
To test if enhancer function could be reliably detected without position effects using the 
PhiC31 integrase transgenesis system, an enhancer-promoter-reporter construct known 
to show strong positional effects using Tol2 transgenesis will be investigated using the 
PhiC31 integrase system.  
5.1.1 Tol2 transgenesis is prone to position effects masking enhancer function 
During a previous study by Yavor Hadzhiev, a putative enhancer was found located in 
the 5th intron of the errɣ gene (Figure 5-1). The 794 bp putative enhancer sequence was 
cloned into a gateway vector containing the keratin4 minimal promoter (krt4) and Venus 
YFP (Figure 3-1). This construct was co-injected with Tol2 mRNA into zebrafish 
embryos and the YFP expression pattern studied at approximately 36-48 hpf. Analysis 
of F0 embryos was unsuccessful in ascertaining whether the putative enhancer was 
driving expression of errɣ as the expression patterns observed were broad, varied and 
did not reflect the pattern expected for the putative target gene (Bardet et al. 2004; 
Thisse et al. 2004). In an effort to reduce the background YFP expression, stable lines 
were made by growing up these injected embryos. When these F0 fish were outcrossed 
to wild type fish and the F1 embryos were screened for YFP expression, different 
transgenic lines showed variability in YFP expression intensity and pattern (Figure 3-1). 
107 
 
 
Figure 5-1 Genome browser view of the putative errɣ enhancer 
This UCSC genome browser view shows the putative errɣ enhancer (red circle) and it’s sequence conservation with 8 other species 
including pufferfish, human and mouse.(black arrow to conservation data in purple). 
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5.1.2 Estrogen-related receptor ɣ 
Errɣ belongs to a group of estrogen-related receptors including Errα and Errβ. As their 
name suggests, they are closely related to the estrogen receptor (ER) family of 
receptors. However, they have no known ligands and are referred to as orphan 
receptors. Errɣ binds to the estrogen response element (ERE) to regulate transcription 
of a number of genes. They have been implicated in breast cancer and other cancers 
and are now the subject of research for treatments of cancer (Ariazi & Jordan 2006). 
As shown in Figure 5-2, Errɣ is expressed in a restricted manner in sections of the 
midbrain and hindbrain as well as the tail bud, somites and pronephric tubes (Bardet et 
al. 2004; Thisse et al. 2004). This was not the pattern observed when studying Tol2 
stable transgenic lines (Figure 3-1) and enhancer function could not be unambiguously 
identified. 
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Figure 5-2 Expression pattern of Errɣ in zebrafish 
(A) In situ shows the expression pattern in a 36hpf embryo – lateral view anterior to the left. Expression is 
visible in the epiphysis (ep), diencephalon (di), hindbrain (hb), somites (som), pronephric tubes (pn) and 
the tail bud (tb). Adapted from (Bardet et al. 2004). (B,C) show the expression pattern in a 48-60hpf 
embryo. Expression can be seen in the retina, midbrain, hindbrain and spinal cord. Adapted from (Thisse 
et al. 2004). (B) is a dorsal view and (C) is a lateral view, both oriented anterior to the left. 
5.1.3 Aims 
To test whether targeted integration of an enhancer-promoter-reporter construct can 
allow the detection of the enhancer‟s function, it will be integrated into the target site of 
recipient line 1. Firstly, the gateway construct will be modified to insert the attB-mCherry 
sequence from the donor vector. The construct will then be co-injected with either Tol2 
mRNA into wild type embryos or with PhiC31 integrase mRNA into recipient line 
embryos. These embryos will then be screened at 48 hpf to analyse the YFP expression 
pattern. The expectation is that PhiC31 integrase will reproducibly restrict expression to 
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those tissues where the enhancer is active. Tol2 is expected to result in the varied, 
broad expression patterns observed previously. 
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5.2 Results 
5.2.1 Modification and testing of the enhancer-promoter-reporter vector  
Firstly, the EL18-krt4-yfp construct obtained from Dr Yavor Hadzhiev, was modified by 
cloning in the attB-mCherry sequence that will allow the construct to be integrated into 
the PhiC31 integrase target site of the recipient line. A schematic of the new vector 
(EL18-krt4-yfp-attB-mCherry) is shown in Figure 5-3; this was then used in the enhancer 
test experiments described below. 
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Figure 5-3 Plasmid map showing the EL18-krt4-YFP-attB-mCherry construct 
Schematic of the vector injected into both wild type and recipient line embryos. It contains Tol2 arms for 
integration into wild type embryos facilitated by Tol2 and the attB-mCherry sequence to allow integration 
into the recipient line by PhiC31 integrase. It also contains the EL18 putative enhancer (purple), keratin4 
promoter (blue) and venus yfp reporter gene (yellow). 
A wild type fish is to be crossed with a heterozygous recipient line fish and the embryos 
will be co-injected with PhiC31 integrase mRNA and the EL18-krt4-yfp-attB-mCherry 
construct (Figure 5-4). The construct was also co-injected with Tol2 mRNA into wild type 
embryos to allow comparisons of the two transgenesis methods (Figure 5-5). 
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Figure 5-4 Schematic showing targeted integration of an enhancer-promoter-reporter construct 
A heterozygous recipient line fish will be outcrossed to a wild type fish (A). The early embryos are to be 
co-injected with an enhancer(E)-promoter(P)-reporter construct containing the donor sequence (attB-
mCherry) and PhiC31 integrase mRNA. This vector will still contain the Tol2 arms (TL and TR) (B). 
Approximately 50% of these embryos will be transgenic and contain the PhiC31 integrase target site. Of 
these, a proportion are expected to show mCherry expression in the lens due to targeted integration into 
the correct locus and YFP expression labelling expression directed by the enhancer (C). The rest will 
show GFP in the lens and no YFP expression as it has not been integrated. 
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Figure 5-5 Schematic to show screening of enhancer using Tol2 transgenesis 
Two wild type fish will be crossed (A) and the early embryos will be co-injected with an enhancer-
promoter-reporter construct containing the donor sequence (attB-mCherry) and Tol2 mRNA (B). A 
proportion of these embryos will be transgenic and have YFP expression labelling expression directed by 
the enhancer but may also show position effects (C).  
5.2.2 YFP expression in the brain region is more restricted and more 
reproducible using PhiC31 integrase as compared with Tol2 transgenesis 
The EL18-krt4-yfp-attB-mCherry was then co-injected into wild type embryos with Tol2 
mRNA. The wild type embryos injected with Tol2 mRNA and the enhancer-containing 
donor construct were screened at 36-48 hpf when Errɣ is known to be expressed in 
zebrafish. Embryos showed mosaic expression throughout many tissues including 
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muscle fibres and skin cells as well as various tissues in the head. There was no 
discernible common expression domain that fit with existing expression data for Errɣ. 
To test whether the YFP pattern would be more restricted and reproducible when 
integration is targeted, the EL18-krt4-yfp-attB-mCherry construct was also injected into 
the recipient line fish along with PhiC31 integrase mRNA. These embryos showed very 
low levels of YFP expression, often only one or two points of YFP fluorescence were 
detected but these were consistently in the hindbrain region. When the expression of 
YFP in certain key tissues was compared between the Tol2 and PhiC31 integrase 
transgenesis systems, it became clear that YFP expression using PhiC31 integrase was 
more restricted and more frequently observed in the hindbrain region (Figure 5-6). This 
data suggests that PhiC31 integrase may also not be suitable for screening enhancers in 
F0 embryos as we could not reveal the pattern of YFP expression matching that of 
endogenous Errɣ. 
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Figure 5-6 Graph showing percentage of embryos expressing transient YFP in a variety of tissues 
The bar chart shows the percentage of 48 hpf embryos showing YFP expression in the most common 
tissues. (* p=0.023) 
5.2.3 Targeted integration gives a more restricted and reproducible YFP 
expression pattern 
In order to overcome issues with mosaicism, the injected embryos described in the 
section above were grown to adulthood in order to make stable transgenic lines. For the 
PhiC31 integrase founders, only the embryos showing mCherry expression in the lens 
were grown up. The Tol2 founders were also selected based on YFP expression; only 
those that showed YFP expression were grown up. Once these fish reached sexual 
maturity at 4 months, they were outcrossed to wild type fish and their embryos were 
screened for YFP expression in order to study enhancer activity in the F1 embryos. The 
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YFP expression pattern was documented at 36 hpf and 60 hpf. Embryos showing YFP 
expression were separated and both pools of embryos were screened for mCherry 
expression in the lens. It was found that all embryos showing YFP expression also 
showed mCherry expression in the lens. Also, all embryos showing GFP expression in 
the lens did not show any YFP expression. This suggests that the only integration was 
into the target site and argues against random integrations independent of PhiC31 
integrase. 
The YFP expression pattern of the recipient line embryos that were co-injected with 
EL18-krt4-yfp-attB-mCherry showed similarities (Figure 5-7) to the endogenous Errɣ 
expression pattern obtained by in situ hybridisation (Bardet et al. 2004; Thisse et al. 
2004). The YFP expression is more restricted than the pattern seen in in situ 
hybridisations; this is to be expected as an enhancer usually drives expression in a 
subset of the full expression domain. 
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Figure 5-7 EL18-krt4-yfp shows similarities to the endogenous Errɣ expression pattern when 
integrated into the target site 
(A) In situ showing expression pattern of Errɣ at prim-15 to prim-25 stage (30-42 hpf). Image was adapted 
from (Bardet et al. 2004) - a dorsal view with anterior to the left. (B and C) In situ showing expression of 
errɣ at high-pec to long-pec stage (42-60 hpf). Image was adapted from (Thisse et al. 2004) - a dorsal 
view (B) and lateral view (C) with anterior to the left. Brightfield (D and G) and YFP fluorescent channel (E 
and H) images of a 60 hpf F1 embryo with targeted integration of the EL18-krt4-YFP construct. (D and E) 
images are dorsal with anterior to the left (G and H) images are ventral with the anterior to the left. (F) 
shows a lateral view of a 48 hpf embryos with targeted integration of EL18-krt4-YFP-attB-mCherry. FB= 
forebrain, MB= midbrain, HB= hindbrain 
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5.2.4 Comparison of PhiC31 and Tol2 transgenesis in stable lines 
To test whether the F1 generation of lines made using the PhiC31 integrase system 
showed a more restricted pattern than the F1 of the lines made using Tol2 transgenesis, 
adult founders were outcrossed and the F1 embryos screened for YFP and mCherry 
expression. Currently, 2 transgenic F1 fish made using PhiC31 integrase have been 
found from 13 adult fish outcrossed (Table 5-1). Both of these lines show an almost 
identical restricted YFP expression pattern specific to small tissues within the brain 
consistent with data for endogenous Errɣ expression (Figure 5-8). 
In total, 4 transgenic F1 fish have been identified from 20 adult fish made using the Tol2 
transgenesis method (Table 5-1). Three of these lines are displayed in Figure 5-8 and 
show different YFP expression patterns that are far broader than the PhiC31 integrase 
embryos shown in panels 4 and 5. This variability in YFP expression pattern in the Tol2 
lines means that no conclusions can be drawn about the similarities between expression 
driven by the putative enhancer and that of endogenous Errɣ. 
This data suggests that using the PhiC31 integrase system to study enhancers in F1 
embryos solves the issue of mosaicism and reduces the background YFP expression 
resulting from position effects that frequently affect enhancer studies using Tol2 
transgenesis. 
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Figure 5-8 Stable lines – Tol2 compared to PhiC31 integrase transgenesis 
Images of 60 hpf F1 embryos from a stable line created using Tol2 (Tol2 L1, 2 and 3) or PhiC31 integrase 
(PhiC31 L1 and 2). Brightfield (BF), YFP channel (YFP) and RFP channel (mCherry) images of dorsal view 
with anterior to the left. 
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Line name 
Founders/total 
fish screened 
Transgenesis rate 
Germline 
transmission 
rates 
ɣcry-attP-GFP 6/36 16.67% 5-60% 
Tg(zp3:PhiC31;zp3:BFP) 5/49 10.20% 9-33% 
Errɣ Tol2 4/20 20.00% 14-80% 
Errɣ PhiC31 2/13 15.38% 8-14% 
Table 5-1 Summary table of rates of transgenesis and germline transmission 
For each transgenic line made, data on the number of founders identified from the number of fish 
screened. The percentage of F1 embryos that were transgenic is also included as the rate of germline 
transmission. 
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5.3 Discussion 
The aim of this work was to establish whether the PhiC31 integrase system could be 
used to study putative enhancers that show too much variability in position effects when 
using Tol2 transgenesis techniques. 
5.3.1 Suitable putative enhancer to test for position effects 
To test the PhiC31 integrase system thoroughly, we needed a construct known to be 
susceptible to position effects and so EL18-krt4-yfp was chosen as the expression 
pattern in four different stable lines was very variable when using Tol2 (Figure 3-1). 
5.3.2 The use of the PhiC31 integrase system for screening F0 embryos 
When embryos injected with EL18-krt4-yfp-attB-mCherry and PhiC31 integrase were 
analysed for YFP expression, it was found that the signal was much weaker and more 
restricted than embryos injected with the same construct along with Tol2 mRNA. The 
expression patterns in PhiC31 integrase injected embryos were more frequently 
observed in the hindbrain region which is consistent with the endogenous Errɣ pattern 
(Figure 5-6). This was a good indication that PhiC31 integrase reduces position effects, 
however the F0 embryos did not reveal whether EL18 is an enhancer of the errɣ gene or 
not because the embryos were mosaic. The mosaicism meant that not enough YFP 
expression was detected to make conclusions about the putative enhancer. 
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5.3.3 Novel in vivo data to support the in silico evidence that the putative 
enhancer found is responsible for driving expression of errɣ 
Stable transgenic lines were made using either Tol2 or PhiC31 integrase in order to 
obtain non-mosaic embryos to see if the enhancer could be studied in the F1 
generation. Three PhiC31 integrase lines have been identified so far and these show 
almost identical expression patterns restricted to specific tissues in the mid- and 
hindbrain (Figure 5-7) (data for third not shown). These expression domains appear to 
be consistent with that of Errɣ in situ data in zebrafish (Bardet et al. 2004; Thisse et al. 
2004). Four Tol2 lines have so far been identified and each of them shows YFP 
expression in the same tissues as the PhiC31 lines but they also show ectopic 
expression that varies between the different Tol2 lines (Figure 5-7). Not only is there 
stronger YFP expression in the Tol2 lines, there are differences in the expression 
domains which cannot be explained by the expression being stronger. 
The expression pattern in the two PhiC31 integrase lines is not identical to the 
expression pattern shown in the in situ image of an embryo at the same stage. This is 
likely due to the tissue-specific nature of enhancers; a gene may have several cis-
regulatory DNA sequences for the different expression domains. Silencers and other 
negative cis-regulatory DNA sequences are not present in the EL18-krt4-yfp-attB-
mCherry construct which may also explain why the YFP expression pattern does not 
exactly recapitulate the endogenous Errɣ pattern. Many spatially restricted genes 
including developmental regulators like the hox genes (Sharpe et al. 1998) and sonic 
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hedgehog (Müller et al. 1999; Woolfe et al. 2004) have a number of cis-regulatory 
elements controlling their expression. 
In situ hybridisation labels RNA which is much less stable than fluorescent proteins. 
Using in situs provides a snapshot in time when RNA is expressed. Using reporter 
genes means that even after expression has stopped, the fluorescent protein is still 
visible allowing visualisation of expression from earlier developmental stages. This may 
explain why the YFP expression shows a more similar pattern to the prim-15 to prim-25 
stage embryo in Figure 5-7A. It also suggests that the enhancer is active at the prim-15 
to prim-25 as the delay in detection of the YFP may be due to the time taken for 
translation of the reporter gene. As it is difficult to compare expression data from in situs 
and in vivo imaging, therefore in situ hybridisation experiments using a YFP probe will 
be carried out to be directly compared with in situ data using an Errɣ probe (see section 
6.4). 
5.3.4 Indicator for targeted integration 
We selected the lens as the marker for the recipient line as it is a small tissue which 
doesn‟t interfere with any tissues in the head and trunk that may be labelled by the 
fluorescent reporter labelling enhancer expression. However, this tissue does not 
develop until 48hpf and sufficient fluorescent protein has to accumulate in order to 
visualise expression. This means that embryos cannot be screened until 3 dpf for 
targeted integration which is after Errɣ has begun to be expressed. Although this is not 
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ideal, the YFP-expressing embryos were separated and the two batches of embryos 
screened separately for mCherry expression in the lens. This still seems to be an 
effective way of studying putative enhancers in vivo. 
5.3.5 Conclusions 
Using the PhiC31 integrase system has allowed me to show in vivo data of a novel 
enhancer that has not previously been published. The data in this chapter shows that 
the El18 enhancer drives expression in tissues that appear to be consistent with the 
endogenous errɣ pattern. Previous experiments using this enhancer sequence could not 
tell us the expression pattern due to the broad expression and variability in patterns 
between different Tol2 lines. This shows the PhiC31 integrase system could be used to 
study novel enhancers in vivo; however, it may not be suitable for all applications of 
zebrafish transgenesis as the reduced survival of injected embryos and the mosaic F0 
mean that it takes about six months in total to study a putative enhancer. 
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6 DISCUSSION 
6.1 Development of a PhiC31 integrase transgenesis system 
The use of the zebrafish model to study cis-regulatory DNA is widespread due to the 
great advantages of this model. However, these studies are sometimes hindered by 
position effects when using popular random integration transgenesis methods. This was 
shown in Figure 3-1 which shows variable, broad expression patterns in F1 embryos 
when the founders were injected with the same enhancer construct. This enhancer 
construct contained a putative enhancer thought to interact with a target gene (errɣ) 
whose expression is restricted to the brain, spinal cord, retina, pronephric tubes and the 
tail bud. The variable, broad expression patterns observed using Tol2 transgenesis are 
thought to be as a result of differences in the flanking genomic DNA surrounding the 
transgene as it integrates randomly.  
In order to reduce variability in position effects compared with random integration, the 
aim of this project is to target each transgene integration to the same genomic locus 
meaning that the flanking genomic DNA will be constant. PhiC31 integrase was selected 
as a targeted integration method as it is already utilised in DrosoPhila transgenesis 
(Bateman et al. 2006).  
Using the PhiC31 integrase system designed with the help of a collaborator I was able to 
show that a donor construct can be integrated into a predetermined genomic locus of a 
transgenic zebrafish embryo. Our system allows the detection of embryos in which 
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legitimate targeted integration has occurred by the switching of fluorescent reporter 
gene expression in the marker tissue (the lens). This rapid in vivo detection of targeted 
integration allows laborious integration site sequence analysis to be avoided.  
Our PhiC31 integrase system facilitates recombination between a single attP site and a 
single attB site resulting in the integration of the whole donor vector. This has two main 
advantages over RMCE in zebrafish which has now been published (Hu et al. 2011): 
recombination between single recognition sites may improve integration efficiency as 
two recombination events occur in RMCE; and integration of the whole vector may be 
better suited to integrating very large DNA sequences, including BACs.  
The targeted integration of BACs would be especially advantageous for the study of cis-
regulatory DNA; BACs may eventually allow all surrounding DNA including all cis-
regulatory elements controlling a target gene to be integrated into a consistent genomic 
context. If this experiment could be carried out enhancer-promoter interactions could be 
thoroughly studied using techniques such as mutagenesis of cis-regulatory elements to 
observe changes in reporter gene activity and chromatin conformation capture (3C) to 
directly study proximity of certain long-range cis-regulatory DNA to the core promoter of 
the target gene. Promoters of target genes could be swapped with promoters of 
bystander genes that are not thought to be driven by the same cis-regulatory elements 
to better understand the mechanisms of enhancer-promoter specificity. Our system 
provides a good basis on which to develop these kinds of methods in zebrafish. 
128 
 
6.2 Reducing mosaicism in transient transgenic zebrafish 
embryos and germline transmission rates 
Injection of zebrafish embryos with DNA constructs, results in only a subset of cells in 
the embryo containing the construct. This is a common problem found with injections in 
zebrafish (Patil et al. 1994), including injections of enhancer-promoter-reporter 
constructs. This results in mosaic expression of the reporter gene and can lead to the 
enhancer function not being revealed in F0 embryos. This mosaicism also reduces the 
efficiency of germline transmission as either none or only a subset of the gametes will 
contain the transgene. The utilisation of Tol2 transposase to facilitate integration of a 
transgene into the genome led to a reduction in mosaicism and an increase in the 
number of founders transmitting the transgene to their offspring (from ~3 % using 
linearised DNA to 50 % using Tol2 transgenesis (Kawakami, Takeda, et al. 2004). If 
mosaicism in injected zebrafish embryos could be further reduced so that an even 
higher proportion of cells contain the transgene, it could improve efficiency of making 
stable transgenic lines used in applications such a cell-labelling and disease modelling 
as well as the study of enhancers.  
The next aim of this project was to try to reduce mosaicism in injected zebrafish 
embryos by integrating the transgene as early as possible after fertilisation. In order to 
do this, PhiC31 integrase protein was provided maternally by making a transgenic line 
using the zebrafish zp3 promoter to drive expression of PhiC31 integrase specifically in 
the oocyte. Transgenesis methods have already been developed using maternal 
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transgenic lines to express integrase proteins in zebrafish (Liu et al. 2008); however, 
they did not test for the presence of Cre before 2 hpf. At the 2 hpf stage, a zebrafish 
embryo already has 64 cells so if the protein has only just been produced, the embryo 
will still show mosaic reporter activity. They do not comment on mosaicism of Cre-
mediated excision, however previous data from the same lab showed GFP expression in 
the adult ovaries and the one cell stage embryo (Liu et al. 2006). Due to the obvious 
presence of functional GFP protein at the one cell stage, the zp3 promoter looked ideal 
to provide functional PhiC31 integrase protein at the time when the donor construct is 
injected. This was expected to result in the earlier integration (within the first few cell 
divisions) of the transgene and therefore show a reduction in mosaicism. Although 
targeted integration into the zebrafish genome was shown to be facilitated when using a 
maternal PhiC31 female founder, there was no evidence to suggest that providing 
functional PhiC31 integrase protein at the time of injection of the donor vector resulted in 
earlier integration to reduce mosaicism.  
Other researchers have begun to use PhiC31 integrase mRNA with a UTR from the 
nanos1 gene which targets the mRNA to the germline precursor cells (Hu et al. 2011) in 
an attempt to boost germline transmission of the transgene. This has showed some 
promising results increasing the percentage of founders which transmit the transgene to 
their offspring from an average of 4.92 % using PhiC31 integrase mRNA (from 4 
experiments) to 50.06 % using PhiC31 integrase mRNA with nanos1 UTR (from 2 
experiments). From the experiment I described in Chapter 5.2.4 I show a transgenesis 
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rate of 15.38 % (Table 5-1) using a higher concentration of PhiC31 integrase mRNA in 
injections. Together, these data suggest that the addition of a nanos1 UTR region to the 
PhiC31 integrase mRNA is the best way to increase transgenesis rates; however this 
does not improve mosaicism in somatic cells of the injected embryo and therefore does 
not allow the study of enhancers in the F0 embryos. 
6.3 Targeted integration of an enhancer-promoter-reporter 
construct reduces ectopic reporter expression thought to be 
due to position effects 
As shown in Figure 3-1, the study of the EL18-krt4-yfp construct using Tol2 transgenesis 
resulted in variable, broad YFP expression patterns that do not correlate with known 
Errɣ expression data (Bardet et al. 2004; Thisse et al. 2004). This is thought to be due to 
the influences of the flanking genomic DNA which, as a result of random integration, is 
different for each injected embryo. To investigate whether targeting the EL18-krt4-yfp-
attB-mCherry construct to the same genomic locus results in a more restricted and 
reproducible YFP expression pattern, it was co-injected with PhiC31 integrase mRNA 
into recipient line embryos. This resulted in a more restricted pattern but expression was 
too low (due to mosaicism) to suggest whether EL18 was an enhancer of errɣ (Figure 
5-6). When non-mosaic F1 embryos from three founders were screened for YFP 
expression, they were both more reproducible and more restricted compared with F1 
from lines made using Tol2 (Figure 5-8). They also shared several similar expression 
domains with endogenous Errɣ (Figure 5-7). These data provide evidence that EL18 
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could be an enhancer that interacts with the errɣ gene in zebrafish. In order to confirm 
this in situ hybridisation experiments will be carried out (see section 6.4). The cis-
regulatory elements have not previously been studied and so this data provides 
evidence that a predicted errɣ enhancer functions in vivo. 
As well as showing in vivo function of a predicted enhancer, these experiments also 
provide evidence that the PhiC31 integrase system can be utilised in experiments 
requiring the study of small changes in gene expression. For example, this system will 
now be used by another PhD student to study changes in reporter expression due to 
point mutations in human enhancers that are thought to be involved in type II diabetes.  
6.4 Future work 
Due to the time constraints of this PhD I was unable to carry out some important 
experiments that would have enabled stronger conclusions to be made from this work. 
These experiments are currently being carried out by another PhD student as part of the 
revisions to the publication submitted to Development (see section 9). Southern blots 
are being carried out on the two recipient lines to establish that only a single copy of the 
integration site is present. A further two enhancers will be tested using the PhiC31 
system developed here to ascertain whether position effects will be reduced when 
studying other putative enhancers. In situ hybridisation experiments are also being 
carried out using a YFP probe and an endogenous errɣ probe to confirm that the YFP 
expression domains overlap with the endogenous errɣ pattern. 
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In order to optimise the system further, more recipient lines could be tested to ensure 
maximum efficiency of PhiC31 mediated recombination and to establish whether the 
YFP pattern would look consistent in five or more different genomic loci. 
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7 APPENDICES 
7.1 Appendix 1 
Primer sequences 
PCR product Forward primer (FP) and reverse primer (RP) 
PhiC31 coding sequence 
FP - ATGGATACCTACGCCGGAG 
RP - TCACACTTTCCGCTTTTTCTTAG 
attB-linker 
FP - GTCGACGATGTAGGTCACG 
RP - CAGCCCGACCGCTGCGCCTTGTCGACATGCCCGCCGT   
Linker-mCherry-pA 
FP - AAGGCGCAGCGGTCGGGCTGGCCGCCACCATGGTGAGCAAGGGCGA 
RP - TGC AAA GTC TGT TCA AGC ATG TG 
attB-linker-mCherry-pA 
FP - GTCGACGATGTAGGTCACG 
RP - TGC AAA GTC TGT TCA AGC ATG TG 
Integration junction 
FP - GGTTCATCGCATGCAGACAG 
RP - CTCGCCCTTGCTCACCAT 
ɣ-crystallin-attP-gfp 
FP - GGTTCATCGCATGCAGACAG 
RP - CTGCTAGTTGAACGCTTCCAT 
attB(83)-linker 
FP - TGACGGTCTCGAAGCCGC 
RP - CAGCCCGACCGCTGCGCCTTGGACCAGATGGGTGAGGTG 
attB(83)-linker-mCherry-pA 
FP - TGACGGTCTCGAAGCCGC 
RP - TGC AAA GTC TGT TCA AGC ATG TG 
ebfp2 coding sequence 
FP - AAATAGGATCCATGGTGAGCAAGGGCGAGG 
RP - AAATTCTCGAGTTACTTGTACAGCTCGTCCATGC 
zp3-PhiC31-pA 
FP - AAAAAGGGCCCGCCCTTAAAATCCCCATGACATG 
RP - AAAAAGCATGCGAATTAAAAAACCTCCCACACCTC 
zp3-ebfp2-pA 
FP - AAAAAGCATGCGCCCTTAAAATCCCCATGACATG 
RP - AAAAAAGATCTGAATTAAAAAACCTCCCACACCTC 
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7.2 Appendix 2 
PhiC31 integrase recognition site sequences 
attP 
84 bp 
AGAAGCGGTTTTCGGGAGTAGTGCCCCAACTGGGGTAAC
CTttgAGTTCTCTCAGTTGGGGGCGTAGGGTCGCCGACATG
ACAC 
attB (original) 
285 bp 
GTCGACGATGTAGGTCACGGTCTCGAAGCCGCGGTGCGG
GTGCCAGGGCGTGCCCttgGGCTCCCCGGGCGCGTACTCC
ACCTCACCCATCTGGTCCATCATGATGAACGGGTCGAGGT
GGCGGTAGTTGATCCCGGCGAACGCGCGGCGCACCGGG
AAGCCCTCGCCCTCGAAACCGCTGGGCGCGGTGGTCACG
GTGAGCACGGGACGTGCGACGGCGTCGGCGGGTGCGGA
TACGCGGGGCAGCGTCAGCGGGTTCTCGACGGTCACGG
CGGGCATGTCGAC 
attB (shorter) 
83 bp 
TGACGGTCTCGAAGCCGCGGTGCGGGTGCCAGGGCGTG
CCCttgGGCTCCCCGGGCGCGTACTCCACCTCACCCATCT
GGTCC 
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